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Postembryonic brain development is dependent on thyroid hormone (T3). The actions of 
T3 are mediated by T3 receptors (TRs) that bind T3 response elements (T3REs) in the genome and 
regulate gene transcription through recruitment of histone-modifying enzymes. Methylation of 
DNA is another critical epigenetic modification that controls gene transcription. Using mouse 
and frog (T3 controls tadpole metamorphosis), I investigated T3-dependent modulation of DNA 
methylation, regulation of genes that control this epigenetic modification, and roles of DNA 
methylation in regulation of gene expression programs in the brain. 
I discovered that TRs directly activate the transcription of the de novo DNA 
methyltransferase 3a (Dnmt3a) gene that encodes a key enzyme that establishes genome-wide 
patterns of DNA methylation in the developing brains of mouse and frog. I identified two 
functional T3REs that support T3-dependent transactivation of the Dnmt3a genes. I found strong 
sequence conservation of the mouse T3REs among eutherian mammals. 
I found that the tadpole brain genome became demethylated during metamorphosis, 
which correlated with activation of genes that are involved in active DNA demethylation (tet2, 
tet3, apobec2, gadd45β, gadd45γ and tdg). Treating premetamorphic tadpoles with exogenous T3 
induced tet3, gadd45γ and tdg mRNAs. I found that T3REs for known T3-regulated genes (klf9 
and dnmt3a) became demethylated during metamorphosis and in response to T3. In vitro 
methylation of DNA fragments containing these T3REs subcloned into reporter plasmids 
abrogated T3-dependent transactivity, suggesting that DNA demethylation of T3REs activates T3-
regulated genes. 
! xv!
To identify gene expression programs that are regulated by DNA methylation, I 
conducted methylated DNA capture sequencing and RNA-sequencing in tadpole brain. I 
identified ~142,000 genomic regions enriched for methylated DNA and 855 regions that showed 
changes during metamorphosis. More than 5,000 genes showed changes in expression, and I 
identified thirteen patterns of expression dynamics and enriched biological pathways among 
these genes. I found an inverse correlation between changes in expression of genes found within 
50 kb neighborhood of regions that became differentially methylated..  
My findings support that T3 modulates DNA methylation in the developing brain, and 
that these changes may be important for the coordination of gene expression programs during 




INTRODUCTION TO THESIS 
 
 Thyroid hormone (TH) plays crucial roles in normal neurological development. Acting 
through its cognate nuclear hormone receptor, TH exerts pleiotropic actions on neural cell 
development by controlling gene transcription through modulation of posttranslational 
modification of histones. While this molecular action of TH is well established, a potential role 
for TH in modulating DNA methylation, another key epigenetic modification that controls gene 
transcription, has not been investigated. In my dissertation research I investigated if TH 
modulates DNA methylation to regulate developmental gene expression programs during 
neurological development. 
 
Roles of thyroid hormone in postembryonic neurological development  
The synthesis of TH is controlled by the hypothalamus-pituitary-thyroid (HPT) axis (1). 
In mammals thyrotropin-releasing factor (TRH) from the hypothalamus stimulates the anterior 
pituitary to release thyroid-stimulating hormone (TSH), which in turn stimulates the thyroid 
gland to release TH into the circulation primarily as thyroxine (T4). At target tissues T4 is 
actively transported into cells and locally converted into more biologically active form of TH 
(3,5,3’ triiodothyronine - T3) by active removal of iodine from T4 catalyzed by actions of type 1 
and type 2 deiodinases.  
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The developing brain is one of the most important target tissues of TH. In humans TH 
starts to influence fetal brain development around 8-10 weeks of gestation, as fetuses express 
detectable levels of TH receptors (2). Thyroid hormone influences various aspects of neural cell 
development, including cell proliferation, migration, differentiation, apoptosis, morphology and 
function (3). Severe deficiency of TH during this period of development leads to an irreversible 
neurological condition known as cretinism characterized by mental retardation and growth 
defects.  
The molecular actions of TH are mediated by TH receptors (TR) that are encoded by two 
genes in vertebrate genomes (Thra and Thrb); the Thra gene encodes TRα, while the Thrb gene 
encodes TRβ (4). The TRs preferentially heterodimerize with another nuclear hormone receptor 
Retinoid X receptor (RXR) and regulate the transcription of target genes by binding to cis-
regulatory elements in the genome (T3 response elements; T3REs). The TR-RXR heterodimers 
preferentially recognize T3REs that are direct repeats of hexanuleotide half sites (5’ AGGTCA 
3’) separated by a four-nucleotide spacer (DR+4), although the half sites could be arranged in an 
inverted, everted or palindromic manner, with a variable length (1-5 bp) of the spacer in between 
(4). The TRs have dual roles in gene transcription as activators and repressors, and binding of 
TH to the receptors modulates their transcriptional activity. In the absence of TH, TRs interact 
with a corepressor complex (NCoR1 – nuclear corepressor; SMRT – silencing mediator of 
retinoid and thyroid hormone receptors) that further recruits histone deacetylases to create a 
chromatin environment that is not permissible for transcription. When TH binds to the receptors, 
this induces a conformational change of TRs to dissociate the corepressor complex, and in 
exchange recruits a coactivator complex that contains histone acetyltransferases (p300, CBP) to 
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promote gene transcription (reviewed in Shi 2009) (5). However, the molecular mechanism by 
which TH controls various aspects of neural cell development is still poorly understood.  
Amphibian metamorphosis is a postembryonic process controlled by TH. Therefore, 
amphibian species such as Xenopus laevis and X. tropicalis have been valuable research models 
to study TH action on tissue morphogenesis including the brain (6). There are several advantages 
of using amphibian tadpoles over mammalian species to study molecular action of TH on tissue 
morphogenesis. First, because tadpoles develop and grow as free-swimming larvae, this removes 
the confounding influence of maternal TH. Second, the hormonal status of tadpoles can be easily 
manipulated by adding TH or TH signaling inhibitors (e.g. the goitrogen, methimazole) to their 
rearing water.  
The HPT axis controls the synthesis and release of TH in amphibians, except that 
corticotropin-releasing factor, instead of TRH, stimulates the release of TSH from the pituitary 
(reviewed in Denver 2013 (7)). At the onset of metamorphosis (NF stage 50) TH level is low. 
Plasma [T3] and [T4] start to elevate during early prometamorphosis (NF stage 54), dramatically 
increase and peak at metamorphic climax (NF stage 62), and then decline at the completion of 
metamorphosis (NF stage 66) (Fig 1.1) (8). The surge of TH drives a dramatic morphological 
transformation of tadpoles that involves tissue generation (e.g. limbs), remodeling of existing 
organs (e.g. brain, intestine) and removal of body parts that are no longer necessary as a frog (e.g. 
tail) (8). Thyroid hormone single-handedly orchestrates these morphological changes in a 
coordinated fashion by activating tissue-specific gene expression programs (9,10). 
 
DNA methylation and enzymes that establish genome-wide patterns of DNA methylation 
(DNA methyltransferases) 
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DNA methylation refers to the transfer of a methyl group (-CH3) from a donor substrate, 
S-adenosylmethionine (SAM), onto the fifth carbon position of cytosines in the genome (5-
methylcytosine; 5-mC). DNA methylation in vertebrate genomes predominantly occurs on 
cytosines of cytosine-guanine (CpG) dinucleotides, and 60-80% of CpG dinucleotides in the 
genome are methylated by actions of enzymes that catalyze DNA methylation, DNA 
methyltrasferases (DNMTs) (11). Three genes encode DNMTs in vertebrate genomes: Dnmt1, 
Dnmt3a and Dnmt3b (in Xenopus genome only dnmt1 and dnmt3a genes have been identified). 
Genome-wide patterns of DNA methylation are first established by DNMT3a and DNMT3b (de 
novo DNMTs), and then maintained through cell divisions by DNMT1 (maintenance DNMT). 
All of these enzymes are essential for normal development; mice carrying mutations for these 
genes are embryonic lethal or die prematurely shortly after birth (12,13). Neural cell-specific 
deletion of DNMT genes in mice causes abnormal neurological development accompanied by 
defective cell differentiation, neurodegeneration and deficits in learning and memory (14-17).  
Recent research has also shown that DNA methylation also occurs on cytosines in the 
context of non-CpG (or CpH, where H = C, T, or A) dinucleotides. CpH methylation was first 
discovered in human embryonic stem (ES) cells (18) and later in somatic cells (19-22); 
interestingly, CpH methylation is most enriched in neural cells (21). The enzyme that catalyzes 
CpH methylation is currently unknown; however, a number of studies support DNMT3a as a 
likely candidate. For example, a recent genome-wide analysis of 5-mC in early postnatal mouse 
and human brain found that a dramatic increase in CpH methylation occurs in parallel with 
upregulation of the Dnmt3a gene (20). Furthermore, other studies have shown that knocking 
down DNMT3a reduces the abundance of CpH methylation in mouse germinal vesicle oocytes 
(23), mouse and human ES cells (24,25), and in mouse brain (19,26). 
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Enzymes that catalyze active DNA demethylation (“DNA demethylases”) 
DNA demethylation refers to the process of removing the methyl group from methylated 
cytosines. In mammals global DNA demethylation occurs during embryogenesis in pre-
implantation embryos and in primordial germ cells (reviewed in Hackett and Surani, 2013) (27); 
Xenopus embryos undergo similar DNA demethylation (28). Genomes can be demethylated 
through passive and active mechanisms. Passive DNA demethylation occurs when the newly 
synthesized DNA does not inherit the pattern of DNA methylation during cell divisions, which 
may occur through exclusion of the maintenance DNMT (DNMT1) from the nucleus (29). It has 
been long speculated that global DNA demethylation during mammalian embryogenesis also 
involved active mechanisms because the decline of 5-mC occurs with faster kinetics than 
predicted by passive mechanisms alone (29). However, the identity of the enzymes that catalyze 
active DNA demethylation remained unknown until 2009 when it was discovered that a family 
of Ten-eleven translocation (TET) enzymes catalyze the conversion of 5-mC to 5-
hydroxymethylcytosine (5-hmC), an oxidized form of 5-mC that is enriched in neural cells 
(30,31). Since this initial discovery, later studies found that 5-hmC serves as a substrate for other 
pathways to complete the process of DNA demethylation (Fig. 1.2). The first pathway involves 
de-amination of 5-hmC to 5-hmU (5-hydroxymethyluracil) by combined actions of activity-
induced cytidine deaminase (AID) and apolipoprotein B mRNA editing enzyme, catalytic 
polypeptide (APOBEC), followed by removal of 5-hmU through the base-excision repair (BER) 
pathway catalyzed by thymine DNA glycosylase (TDG) (29). Another pathway involves further 
oxidation of 5-hmC by TET proteins to 5-formylcytosine (5-fC), then to 5-carboxylcytosine (5-
caC) (32,33). 5-fC and 5-caC can be then removed by the TDG-mediated BER pathway (32,34), 
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or by the nucleotide excision repair pathway mediated by growth arrest and DNA damage 
(GADD45) proteins (35).  
 
DNA methylation and gene regulation 
 Prior studies have established a role for DNA methylation in transcriptional regulation. 
Once cytosines become methylated by actions of DNMTs, methylated DNA can either directly 
block binding of transcription factors when their recognition motifs contains CpG dinucleotides, 
or recruit additional proteins that have affinity for methylated cytosines, such as a family of 
methyl-CpG binding proteins (MBD: MeCP2, MBD1-4) (36). These MBD proteins interact with 
a protein complex that contains histone deacetylases such as Sin3A (37) to establish chromatin 
architecture that is not permissive for transcription. Therefore, in general, DNA methylation is 
associated with gene repression, while DNA demethylation promotes gene activation.  
DNA methylation at gene regulatory regions follow this general rule, as there is an 
inverse correlation between expression of nearby genes and DNA methylation at promoters, 
around transcription start site, within intragenic region (gene body), and cell-type specific active 
enhancers (20,38,39). There is also a strong positive correlation between the level of 5-hmC 
within the gene body and the transcript abundance of the associated genes (40-42), which is 
consistent with 5-hmC being an intermediate of active DNA methylation. In vertebrate genomes 
CpG dinucleotides are often present in clusters (termed ‘CpG islands’), and many CpG islands 
overlap with promoters of constitutively active (i.e. house-keeping) genes; these regions are 
generally free of DNA methylation to keep the promoters active (43). 
On the other hand, there are examples where DNA methylation does not correlate with 
gene repression. For example, Wu et al. (2010) showed that DNA methylation of non-promoter 
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regions led to gene activation by preventing the recruitment of Polycomb repressor complex 
(PRC) 2 that catalyzes the deposition of tri-methylation on lysine residue 27 of histone 3 
(H3K27me3), which is a repressive histone mark. It has also been shown that MeCP2, which is 
normally a repressor, could activate genes by associating with a transcriptional coactivator 
CREB1 (44). Therefore, the repressive role of CpG methylation appears to be dependent on the 
location within the genome and the nature of proteins recruited by MBDs. The regulatory role of 
CpH methylation is still not well understood because of its recent discovery in vertebrate 
genomes. However, available data suggests that it is also a repressive mark like CpG methylation. 
For example, Lister et al. (2013) showed that intragenic CpH methylation inversely correlated 
with the amount of transcript for the associated genes (20). 
DNA methylation plays a number of important roles during development, such as X-
chromosome inactivation and imprinting. X-chromosome inactivation refers to the dosage-
compensation mechanism in mammals to silence one of X-chromosomes in XX females 
(reviewed in Deng et al., 2014 (45)). Silencing of X-chromosome is regulated by Xist long non-
coding RNA, which is actively transcribed from the inactive X-chromosome, whereas it is 
silenced on the active X-chromosome. The 5’ region of the Xist gene is differentially methylated 
between active and inactive X-chromosomes; it is hypermethylated on the active X-chromosome 
to silence the Xist gene and hypomethylated on the inactive X-chromosome to keep Xist gene 
transcription active (46). It has been shown that disrupting this differential pattern of DNA 
methylation leads to abnormal reactivation of the inactive X-chromosome (47,48). Imprinting 
refers to the pattern of differential gene expression between the two alleles, where one parental 
copy is preferentially expressed over the other depending on the sex of the parent transmitting 
the allele. For example, the Igf2 (insulin-like growth factor 2) gene in mammals is expressed 
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only from the paternal allele (reviewed in Nordin et al., 2014 (49)). Almost all imprinted genes 
are associated with differentially methylated regions (DMRs) (50), and previous studies have 
established a direct linkage between the Igf2 gene transcription and the methylation state of 
DMRs associated with the gene (49). 
 
Role of DNA methylation in neurological development  
In humans Rett syndrome best exemplifies the critical role that DNA methylation plays in 
postembryonic neurological development. Rett syndrome is caused by mutations in the X-linked 
gene that codes for MeCP2, which binds to methylated cytosines through its methyl-CpG 
binding domain (51). The affected individuals develop normally up to ~6 months of age, then 
start to display symptoms such as mental retardation, loss of speech and abnormal gait (51). 
Mice carrying mutations in the homologous MeCP2 gene recapitulate the neurological and 
behavioral symptoms seen in humans (52,53). These disease-associated phenotypes can be 
partially rescued by re-expressing MeCP2 in post-mitotic neurons (54), suggesting their roles in 
mature neuronal cells. Indeed, the MeCP2 protein is expressed as abundantly as histone proteins 
in post-mitotic neurons (55).  
Although MeCP2 was originally identified as a protein that binds to methylated CpG 
dinucleotides (hence the name ‘methyl-CpG binding’), it also binds to methylated CpA 
dinucleotides with a similar affinity to methylated CpGs (26). Recent studies have shown that 
MeCP2 preferentially binds to brain-specific genes in a manner that is dependent on the density 
of CpA methylation and the transcript length (26,56), suggesting a role for CpA methylation in 
Rett syndrome. A recent, comprehensive genome-wide mapping of 5-mC revealed a dramatic 
increase in CpA methylation in the developing mammalian brains, coincident with the period of 
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synaptogenesis and synaptic pruning (20), further suggesting roles for DNA methylation in 
normal neurological development.  
 
Thesis Summary 
In this thesis I describe studies that investigated T3-dependent modulation of DNA 
methylation during postembryonic brain development. In Chapter 2, I describe work that 
investigated T3-dependent transcriptional regulation of the DNA methylatransferase 3a (Dnmt3a) 
gene that codes for a key enzyme that catalyzes de novo DNA methylation. I discovered that the 
Dnmt3a gene is directly activated by TRs in the developing brains of mouse and frog. I also 
identified and characterized two DR+4 T3REs associated with the gene. Although sequence 
alignment analysis did not support orthology between mouse and frog Dnmt3a T3REs, I found a 
strong conservation for both of the mouse Dnmt3a T3REs among eutherian mammals, suggesting 
that transcriptional regulation of the Dnmt3a gene by T3 is an evolutionary conserved and ancient 
mechanism to modulate DNA methylation in the developing brain. 
Published work and my findings in Chapter 2 suggested that the neural cell genome 
undergoes changes in DNA methylation during postembryonic development, and I further 
investigated this in Chapter 3 using Xenopus tadpoles. Contrary to what I expected from findings 
in Chapter 2, I discovered that the genome of tadpole neural cells became demethylated during 
metamorphosis, which correlated with increases in mRNAs for genes that code for enzymes that 
catalyze active DNA demethylation (tet2, tet3, apobec2, gadd45β, gadd45γ and tdg); tet3, 
gadd45γ and tdg mRNAs also showed T3-dependent increases in premetamorphic tadpole brain. 
I also discovered that regions that contain T3RE for known T3-regulated genes (krüppel-like 
factor 9 – klf9 and dnmt3a) became demethylated in tadpole brain during metamorphosis, and 
! 10!
this correlated with increases in klf9 and dnmt3a mRNAs. I further showed that in vitro 
methylation of DNA fragments that encompassed klf9 and dnmt3a T3REs impaired T3-dependent 
transactivity, suggesting that modulation of DNA methylation at T3REs may regulate 
transcriptional activation of T3-regulated genes in the developing brain.  
Findings in Chapter 3 suggest that modulation of DNA methylation support T3-dependent 
gene expression changes in tadpole brain during metamorphosis. To identify gene expression 
programs that are regulated by changes in DNA methylation, I conducted methylated DNA 
capture sequencing (MethylCap-seq) and RNA-sequencing (RNA-seq) in Xenopus tadpole brain 
at different stages of metamorphosis, which is described in Chapter 4. I identified ~142,000 
genomic regions that are enriched for methylated DNA; however, only a small number of 
regions (855) exhibited changes in DNA methylation (differentially methylated regions – DMRs). 
On the other hand, I identified more than 5,000 differentially expressed genes in tadpole brain 
during metamorphosis. By combining MethylCap-seq and RNA-seq data I investigated the 
potential correlation between changes in DNA methylation and expression of genes that are 
found in 50 kb vicinity of DMRs. While the majority of genes did not show correlated changes in 
expression, my analysis supported an inverse correlation between changes in DNA methylation 
and gene expression changes. 
In summary, my findings support that T3 modulates DNA methylation in the developing 
brain via activation of genes that are involved in DNA methylation and active DNA 
demethylation. My discoveries have important implications for understanding the mechanisms 
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Fig. 1.1. Correlation of plasma thyroid hormone (T3 and T4) concentration with Xenopus 
laevis metamorphosis. Developmental stage is assigned according to the normal table of X. 










Fig. 1.2. Active DNA demethylation pathways. Ten-eleven translocation (TET) enzymes 
initiate the process of active DNA demethylation by catalyzing the conversion of 5-
methylcytosine (5-mC) to 5-hydroxymethylcytosine (5-hmC). The first pathway involves de-
amination of 5-hmC to 5-hmU (5-hydroxymethyluracil) by combined actions of activity-induced 
cytidine deaminase (AID) and apolipoprotein B mRNA editing enzyme, catalytic polypeptide 
(APOBEC). This is followed by removal of 5-hmU through the base-excision repair (BER) 
pathway catalyzed by thymine DNA glycosylase (TDG). The second pathway involves TET-
mediated oxidation of 5-hmC to 5-formylcytosine (5-fC), then to 5-carboxylcytosine (5-caC). 5-
fC and 5-caC are then removed by the TDG-mediated BER pathway, or by the nucleotide 
excision repair pathway mediated by growth arrest and DNA damage (GADD45) proteins 








THYROID HORMONE RECEPTORS DIRECTLY REGULATE TRANSCRIPTION OF 




 Thyroid hormone (T3) is essential for vertebrate neurological development. Thyroid 
hormone receptors control gene transcription by modulating chromatin structure through 
posttranslational modifications of histones. Methylation of DNA is another key epigenetic 
modification influencing gene transcription. Patterns of DNA methylation are established by the 
de novo DNA methyltransferases (DNMT) 3a and 3b, and maintained by DNMT1. Using 
Xenopus tadpole metamorphosis, a T3-dependent process, I discovered that dnmt3a mRNA 
increased in tadpole brain during spontaneous metamorphosis and could be induced in 
premetamorphic tadpoles by exogenous T3. I identified two T3 response elements (T3REs) within 
dnmt3a at -7.4 kb and +4.7 kb relative to the predicted translation start site to explain T3 
regulation of the gene.  In mouse brain the postnatal rise in plasma T3 and expression of Dnmt3a 
are positively correlated. I therefore investigated whether Dnmt3a was similarly regulated by T3 
in mouse as in frog. Injection of T3 into postnatal day 6 mice increased Dnmt3a mRNA in the 
brain. Treatment of the mouse neuroblastoma cell line Neuro2a[TRβ1] with T3 caused a rapid 
increase in Dnmt3a mRNA. I identified two functional T3REs within the mouse Dnmt3a locus at 
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+30.1 kb and +49.0 kb from the transcription start site; they are highly conserved among 
mammalian species, but do not appear to be orthologous with the frog dnmt3a T3REs. Thyroid 
regulation of Dnmt3a may be an ancient feature in vertebrates, but the ancestral genomic sites 
responsible for hormone regulation may have diverged, or arisen by convergent evolution. I 
hypothesize that T3 regulation of Dnmt3a is an important mechanism for modulating global 





 DNA methylation of the carbon-5 position of cytosines (5-methylcytosines; 5-mC) is an 
epigenetic modification that is critical for controlling gene expression. In most vertebrate cells 
cytosine methylation in DNA occurs predominantly in the context of cytosine-guanine (CpG) 
dinucleotides, but recent findings showed that it is also present as a form of CpH methylation 
(where H = A, T or G) (1). Genome-wide DNA methylation pattern is established during 
embryogenesis by the de novo by DNA methyltransferases DNMT3a and 3b, and maintained 
through rounds of cell division by DNMT1. DNA methylation at gene regulatory loci can lead to 
gene silencing through direct inhibition of transcription factor binding or recruitment of methyl-
CpG binding domain (MBD) proteins, such as MeCP2, that recruit chromatin modifying 
enzymes such as histone deacetylases to establish a repressive chromatin state (2).  
 In addition to established roles in X-chromosome inactivation, genomic imprinting and 
silencing of transposable elements during embryogenesis (3), DNA methylation plays crucial 
roles in postembryonic maturation of the developing brain. For example, a recent comprehensive 
genome-wide analysis of 5-mC in the developing frontal cortices in human and mouse found a 
dramatic increase in the abundance of 5-mC, mostly in the CpA context, that coincides with a 
period of synaptogenesis during early postnatal weeks (4). Mutations in the X-linked MECP2 
gene in humans causes Rett syndrome, where affected individuals gradually lose acquired speech 
and motor skills and develop mental retardation by 6-18 months of age (5). Dnmt3a knock-out 
mice die prematurely at four weeks of age (6) with signs of defective neurogenesis in the 
subventricular zone (SVZ) of the brain (7).  
 Thyroid hormone plays critical roles in vertebrate development, which was first shown in 




hormone has pleiotropic actions in neurological development, influencing neural cell 
proliferation, migration, differentiation, apoptosis, morphology and function, but the molecular 
basis for these actions are poorly understood (8). Thyroid hormone acts to control gene 
transcription via ligand-modulated transcription factors (TRs) that bind T3 response elements 
(T3RE) in the genome typically in heterodimerization with retinoid X receptor (RXR). For genes 
that are activated by T3, unliganded TRs repress transcription through interaction with a 
corepressor complex that recruits histone-modifying enzymes such as histone deacetylases to 
create a closed chromatin structure. By contrast, liganded TRs activate transcription through 
recruitment of a coactivator complex that includes histone acetyltransferases that acetylate lysine 
residues on histone tails to generate an open chromatin structure (9).  
 While the roles of TRs in controlling histone modifications have been extensively studied, 
it is not known whether TH acting through TRs can influence DNA methylation. In the present 
study I investigated T3 regulation of the Dnmt3a gene in Xenopus and mouse brain, and in mouse 
neurobastoma cells (Neuro2a[TRβ1]). I found that Dnmt3a is regulated in a developmental stage 
and T3-dependent manner in both species. Furthermore, I identified and characterized functional 
T3REs in Xenopus and mouse Dnmt3a genes. My findings support the hypothesis that TH 
influences DNA methylation in the developing brain through direct regulation of Dnmt3a. 
 
Materials and Methods 
Animal care and thyroid hormone (T3) treatment of animals 
Xenopus laevis tadpoles were obtained by in-house breeding, reared in dechlorinated tap 
water (21 – 23 °C), maintained at 12L:12D photoperiod and fed ad libitum with pulverized frog 




(1994) was used to assign developmental stages.  
For gene expression analyses I placed premetamorphic X. laevis tadpoles (NF stage 50) in 
aquaria containing two liters of water 24 hr prior to hormone treatment. Thyroid hormone 
(3,5,3′-L-triiodothyronine; T3 sodium salt; Sigma-Aldrich, St. Louis, MO) was first dissolved in 
dimethylsulfoxide (DMSO) and directly added to the aquarium water. I treated animals with 
vehicle (0.0003% DMSO) or T3 (5 nM) for different times before harvest. Twenty-four hours 
after hormone treatment was initiated, the water was exchanged and T3 was replenished. 
Tadpoles were killed by rapid decapitation, brains were dissected, and either snap frozen in 
liquid nitrogen and stored at –80 °C until RNA extraction, or fixed for in situ hybridization 
histochemistry (ISHH; described below). 
I purchased wild-type C57BL/6J mice from the Jackson Laboratory (Bar Harbor, ME) 
and maintained them at 12L:12D photoperiod with food and water provided ad libitum. Neonatal 
mice were obtained by in-house breeding. For gene expression analysis I administered 
intraperitoneal (i.p.) injections at postnatal day 6 (PND6) of vehicle (corn oil + EtOH) or T3 (25 
μg/kg body weight - BW). The T3 was first dissolved in EtOH at high concentration and then 
added dropwise to corn oil with vigorous mixing (final concentration 0.05% EtOH). Mice were 
killed by rapid decapitation one hr after injection. The hippocampal region of the brain was 
dissected, snap frozen in liquid nitrogen and stored at –80 °C until RNA extraction. 
For chromatin immunoprecipitation (ChIP) assays, I administered i.p. injections of T3 (25 
μg/kg BW) to PND14 mice of mixed sexes (n=5). Mice were killed by rapid decapitation four 
hrs after injection. Frontal cortex, the hippocampus and the cerebellum were dissected, and 
chromatin was extracted immediately after dissection, snap frozen in liquid nitrogen and stored 




conducted in accordance with the guidelines of the University Committee on the Care and Use of 
Animals of the University of Michigan. 
 
RNA extraction and reverse transcriptase real-time quantitative PCR (RT-qPCR) 
I extracted total RNA from tissues or cells using TRIZOL reagent (Invitrogen Life 
Technologies, Carlsbad, CA). Prior to cDNA synthesis, I treated the total RNA with 20 units of 
deoxyribonuclease I (DNAse I) (Invitrogen) in the presence of RNAse inhibitor (Roche Applied 
Sicence, Indianapolis, IN). I reverse transcribed cDNA using the High Capacity cDNA Synthesis 
Kit (Applied Biosystems Inc. (ABI), Foster City, CA). I conducted real-time qPCR using 
ABsolute Blue qPCR SYBR Low ROX Mix (ABgene Thermo Scientific, Surrey, UK) and Fast 
7500 Real-Time PCR System (ABI) or StepOne Real Time PCR Systems (Life Technologies). 
Primers were designed to span exon/exon boundaries for each target gene (Supplemental Table 
2.1). A relative quantification method (10,11) was used to compare gene expression levels across 
developmental stages or among treatments by generating standard curves for each gene with a 
pool of cDNAs. Xenopus laevis dnm3a mRNA (Genbank Accession# BJ059684) was normalized 
to alpha-actinin mRNA (NM_001090829.1), and mouse Dnmt3a mRNA (NM_007872) was 
normalized to GAPDH mRNA (NM_008084). Both alpha-actinin and GAPDH mRNAs did not 
change across development or with hormone treatment. 
 
In situ hybridization histochemistry (ISHH) 
I analyzed the spatial distribution of dnmt3a mRNA in X. laevis tadpole brain using 
ISHH as previously described (12). I isolated a partial cDNA for X. laevis dnmt3a (591 bp), 




orientation and sequence by direct DNA sequencing. I synthesized sense and antisense 
riboprobes from the linearized plasmid using the DIG RNA Labeling Kit (Sp6/T7) (Roche). I 
hybridized 200 ng of sense or antisense riboprobes to cryosections (12 µm) at 65°C overnight. 
The RNA hybrids were detected using monoclonal sheep anti-digoxigenin antibody cojugated to 
alkaline phosphatase (1:500; Roche). Primary immune complexes were detected by colorimetric 
reaction with NBT/BCIP (nitro-blue tetrazolium chloride and 5-bromo-4-chloro-3’-
indolyphosphate p-toluidine) (Roche). The specificity of the riboprobe was determined by: 1) the 
absence of signal with sense probe on the adjacent sections (Supplemental Fig. 2.1); and/or 2) 
the absence of signal with antisense probe in cryosections of vehicle-treated animals. All sections 
were carefully matched for anatomical level, and digital micrographic images were captured 
using an Olympus IX81 inverted microscope (Olympus, Tokyo, Japan). Brightness, contrast, and 
evenness of illumination were adjusted uniformly for images shown in the figures using Adobe 





Xenopus tropicalis dnmt3a T3REs: A chromatin interaction analysis by paired-end tag 
sequencing (ChIA-PET) with TR as the target protein was conducted on chromatin isolated from 
X. tropicalis tadpole tail fin to identify TR binding sites and their long range interactions in 
chromatin (L. Sachs and N. Buisine, unpublished data). This analysis identified three putative 
TR binding sites in the frog dnmt3a gene. The coordinates of these three genomic loci (regions A, 
B and C) are provided in Supplemental Table 2.2. I subcloned genomic fragments corresponding 




and SacI sites. Region C was not subcloned because I did not find TR association in the tadpole 
brain by chromatin immunoprecipitation (ChIP) analysis (see Results). 
Mouse Dnmt3a T3REs: I used data from TR ChIP sequencing (ChIP-seq) analyses 
conducted on chromatin isolated from mouse liver (13) or the C17.2 mouse cerebellar cell line 
(14) to identify putative TR binding sites at the mouse Dnmt3a locus. This analysis, described in 
the Results, identified two candidate genomic regions, one at +30.1 kb and another at +49.0 kb 
relative to the TSS (these fell within the second and third introns, respectively, of the mouse 
Dnmt3a gene). I subcloned 500 bp genomic fragments corresponding to these regions into the 
pCpGL luciferase vector (gift of Michael Rheli) at the BglII and HindIII sites (+30.1 kb 
fragment), or into pGL4.23 at the KpnI and SacI sites (+49.0 kb fragment).  
I generated point mutations in predicted T3REs within the subcloned genomic fragments 
by site-directed mutagenesis (primer sequences in Supplemental Table 2.3) using the 
QuikChange II Site-Directed Mutagenesis Kit (Agilent Technologies, Santa Clara, CA). 
Chromatin immunoprecipitation (ChIP) assays 
I conducted ChIP assays as previously described (15) with minor modifications. For X. 
laevis, I prepared chromatin from the whole brain of premetamorphic tadpoles (NF stage 50; 18 
pooled per sample, n=4) treated with vehicle (0.0003% DMSO) or T3 (5 nM) for 48 hr, and from 
untreated tadpoles at metamorphic climax (NF stage 62; 5 pooled per sample, n=4). For mouse, I 
prepared chromatin from Neuro2a[TRβ1] cells treated with vehicle (0.1% DMSO) or T3 (30 nM) 
for 24 hr (n=4/treatment), and chromatin from the frontal cortex of the brain of PND14 mouse 
that received i.p. injection of T3 (25 µg/kg BW) four hr before sacrifice (n=5). I sonicated all 
chromatin samples to ~500 bp using a sonic dismembrator 100 (Fisher, Fair Lawn, NJ) for a total 




cycle) at an output rating of 5-6 watts. All chromatin samples were snap frozen in liquid nitrogen 
and stored at -80 °C until analysis. 
I used the following primary antibodies for ChIP assays: a rabbit polyclonal antiserum 
raised against the full-length X. laevis TRβ (PB antiserum, which recognizes both TRα and TRβ 
in frog and mouse; 5 µl; gift of Yun-Bo Shi) (15), anti-histone 3 (H3) (5 µl; Millipore, Billerica, 
MA; #07-670), or anti-acetylated H3 (AcH3) (5 µl; Millipore #06-599). Negative controls for the 
assay included the replacement of the primary antibody with straight normal rabbit serum (NRS, 
for the PB antiserum) or IgG purified from NRS (16). I measured ChIP DNA by real-time qPCR 
using SYBR Green assays. 
 
Electrophoretic mobility shift assays (EMSA) 
 
 I conducted EMSA as previously described (17). Xenopus TRβ and retinoid X receptor 
alpha (RXRα) proteins were in vitro synthesized using pSp64a-TRβ and pSp64a-RXRα 
plasmids (gift of Yun-Bo Shi) and the TnT SP6 Quick-Coupled Translation System (Promega). I 
used radioinert duplex oligonucleotides (1 µM) as competitors in competitive EMSA 
(Supplemental Table 2.3). 
 
Cell culture and transient transfection assays 
Neuro2a is a neuroblastoma cell line that was derived from a spontaneous brain tumor of 
a strain A albino mouse (American Type Culture Collection). I used Neuro2a engineered to 
express the TRβ1 isoform (Neuro2a[TRβ1]) (18). I cultured cells as previously described (15) in 
DMEM/F12 containing 10% fetal bovine serum that had been stripped of thyroid hormone (19) 




per well in 6-well plates for RNA analysis, 1.25 X 106 per well in 6-well plates for ChIP, and 
0.15 X 106 per well in 24-well plates for transient transfection-reporter assays. 
For RNA analysis and ChIP assay, I incubated cells overnight before treatment with 
vehicle (0.1% DMSO) or T3 (30 nM) for different times before harvest.  
I transfected cells with luciferase reporter constructs (described above; 200 ng per well 
plus 10 ng pRenilla-tk) using FuGene 6 transfection reagent (Promega, Madison, WI) when cells 
had reached 60-70% confluency. Twenty-four hr after transfection I treated cells with vehicle 
(0.1% DMSO) or T3 (30 nM) for 5 or 24 additional hr before harvest for analysis by dual 
luciferase assay (Promega). I consistently observed a ~2 fold reduction of the relative light units 
(RLU) in the T3-treated group transfected with the pGL4.23 empty vector. For this reason I 
corrected the RLU for the T3-treated groups by multiplying it by a correction factor. The 
correction factor was calculated by dividing the RLU from the vehicle treated groups transfected 
with pGL4.23 empty plasmid by the RLU in the T3-treated groups transfected with pGL4.23 
empty plasmid, which was approximately 2. 
To determine whether T3-induction of dnmt3a mRNA required ongoing protein synthesis, 
I treated cells with 10 µg/ml cycloheximide (CHX) (Sigma-Aldrich) for a total of 7 hr before 
harvest, 1 hr before and 6 hr during T3 treatment (the CHX suppressed ongoing protein synthesis 
by >95% - Bagamasbad et al. 2015). 
 
Data analysis and statistics  
I analyzed data using SPSS statistical software (version 19; SPSS Inc., Chicago, IL). I 
conducted one-way ANOVA followed by Fisher’s least significant difference (Fisher’s LSD) 




before statistical analysis for the derived values or when the variances were found to be 
heterogeneous. 
I searched for putative direct repeat with four base spacer (DR+4) T3REs using the 
sequence analysis program Vector NTI (version 10; Invitrogen) with “TGWCCYnnnnTGWCCY” 
as a search term with 3 base-pair mismatches allowed. I used AlignX module of Vector NTI for 
sequence alignment analyses shown in Supplemental Figures. 2.2, 2.6 and 2.8. 
 
Results 
Dnmt3a mRNA exhibits developmental and T3–dependent changes in Xenopus tadpole 
brain  
Using real-time RT-qPCR I found that treatment of premetamorphic (NF stage 50) X. 
laevis tadpoles with T3 added to the aquarium water (5 nM) caused a time-dependent increase in 
dnmt3a mRNA in tadpole brain (Fig. 2.1A). I confirmed and extended these findings using ISHH, 
which showed expression in different brain regions including the anterior preoptic area, thalamic 
nuclei, the suprachiasmatic nucleus, the ventral hypothalamus and the optic tectum (Fig. 2.1B 
and 1C; shown are two transverse planes, the region of the ventral hypothalamus and thalamic 
nuclei [1] and the optic tectum and tegmentum [2]).  
 The dnmt3a mRNA level analyzed by RTqPCR (Fig. 2.1D) and by ISHH (Fig. 2.1E) 
exhibited dynamic changes in tadpole brain during spontaneous metamorphosis. It was low 
during premetamorphosis to early prometamorphosis (NF stages 50-54), increased during late 
prometamorphosis (from NF stage 54 to 58), peaked at metamorphic climax (NF stage 62) and 
declined at the end of metamorphosis (NF stage 66; hybridization with sense probe gave no 




tadpoles with the goitrogen methimazole did not alter dnmt3a mRNA in tadpole brain, although 
this treatment reduced mRNA for a known direct TR target gene (krüpple-like factor 9 - klf9) 
(data not shown) 
 I detected ISHH signal in the same brain regions as for the premetamorphic tadpole 
(treated with T3 for 48 hrs). However, unlike when the expression was induced by exogenous T3 
in the premetamorphic tadpole brain, during spontaneous metamorphosis dnmt3a mRNA was 
excluded from cells located in the ventricular and subventricular zones (VZ and SVZ; 
neurogenic regions) where neural stem cells proliferate and give rise to neurons and glia (Fig. 
2.1E; Supplemental Fig. 2.1). 
   
Identification of T3 response elements at the frog dnmt3a locus 
By analyzing data from a ChIA-PET experiment conducted on tadpole tail fin chromatin 
with TR as the target protein (L. Sachs and N. Buisine, unpublished data) I identified three 
putative TR binding sites within the X. tropicalis dnmt3a locus: one located at 7.4 kb upstream of 
the predicted translation start site (“region A”), a second at 4.7 kb downstream of the predicted 
translation start site within the intron between coding exons 1 and 2 (“region B”), and a third at 
8.2 kb downstream of the predicted translation start site within the intron between coding exons 
2 and 3 (“region C”) (Fig. 2.2; see Supplemental Table 2.2 for genomic coordinates of these 
regions). The annotation for this locus in the X. tropicalis genome has not been resolved. While I 
are confident that these are the first three coding exons based on comparison of the predicted 
gene structure with that of the mouse Dnmt3a gene, I do not know the exact numbering of the 
exons or introns. For this reason I express distances relative to the predicted translation start site. 




(Supplemental Fig. 2.2).  
I conducted targeted ChIP analysis for TR association with regions A, B and C in brain 
chromatin isolated from premetamorphic X. laevis tadpoles (NF stage 50) treated with or without 
T3 for 48 hr, and in chromatin from tadpoles at metamorphic climax when endogenous plasma 
[T3] peaks (20). This showed enrichment of the TR ChIP signal at region A in all treatments (Fig. 
2.2). The TR ChIP signal was also enriched at region B, but only in metamorphic climax (NF 
stage 62) animals. The TR ChIP signal was at background levels in all treatments at region C 
(Fig. 2.2).  
Computer analysis identified three putative DR+4 T3REs located within each of the 
genomic regions A and B of the X. tropicalis dnmt3a locus (xT3RE-A1-3 and xT3RE-B1-3; 
Supplemental Fig. 2.2). Using comparative genomic sequence analysis of the homologous 
regions of the two X. laevis dnmt3a genes (X. laevis is pseudotetraploid, while X. tropicalis is 
diploid) I found sequence conservation for one of the T3REs within each of these regions 
(xT3RE-A1 and xT3RE-B2) (Supplemental Fig. 2.2). Electrophoretic mobility shift assay using 
oligonucleotide probes containing these conserved T3REs showed that TRβ-RXRα heterodimers 
bound to both sequences in vitro (Fig. 2.3A). Competitive EMSA confirmed that radioinert 
duplex olingonucleotides or genomic fragments containing these sequences displaced TRβ-
RXRα from the radiolabled probe (Supplemental Fig. 2.3). 
To test for functionality of these putative T3REs I conducted transient transfection-
reporter assays in Neuro2a[TRβ1] cells using luciferase reporter constructs containing X. 
tropicalis genomic fragments corresponding to regions A (300 bp) and B (326 bp). Treatment 
with T3 caused a significant increase in luciferase activity in cells transfected with these 




two half sites of the T3RE-A1 and T3RE-B2 sequences (Fig. 2.3B). 
 
Dnmt3a mRNA exhibits developmental and T3–dependent changes in neonatal mouse 
brain, and is induced by T3 with rapid kinetics in mouse neuroblastoma cells  
Given the strong developmental and T3-dependent regulation of dnmt3a in Xenopus 
brain, I investigated whether the orthologous mouse gene was similarly regulated by TH, and 
thus if this was an evolutionarily conserved mechanism in vertebrates to control DNA 
methylation during postembryonic neural development. Published work supports that there is a 
parallel increase in circulating plasma [T3] and [T4] with Dnmt3a mRNA and protein in mouse 
brain during postnatal days 4 (PND4) to PND14 (4,21-23) (Supplemental Fig. 2.4). In addition, a 
recent meta-analysis of published microarray studies listed Dnmt3a as one of 734 candidate TH-
regulated genes in rodent brain (24). I found that intraperitoneal injection of T3 at PND6 
increased Dnmt3a mRNA in neonatal mouse brain (hippocampal region) at 1 hr after injection, 
supporting TH regulation of the gene (data not shown). To further investigate TH regulation of 
Dnmt3a in mouse neuronal cells I treated the neuroblastoma cell line Neuro2a[TRβ1] with T3 (30 
nM). This caused a rapid, time-dependent increase in Dnmt3a mRNA (Fig. 2.4A), and this 
increase did not require ongoing protein synthesis (cycloheximide experiment; Fig. 2.4B), thus 
supporting that mouse Dnmt3a is a direct T3-response gene. 
 
Identification of T3 response elements at the mouse dnmt3a locus 
By analyzing data from TR ChIP-seq experiments conducted in mouse liver (13) and in 
the C17.2 mouse cerebellar cell line (14), I identified thirteen putative TR binding sites 




these putative TR binding sites). Using this information I conducted targeted ChIP assays for TR 
association at these genomic regions using chromatin isolated from mouse frontal cortex as 
published work (4,21) showed that DNMT3a is expressed throughout the mouse brain and that 
its peak expression occurs in the frontal cortex at PND14 (Supplemental Fig. 2.4). Of the thirteen 
predicted sites, I confirmed that TR associated with two, one within the second intron at +30.1 
kb from the transcription start site (TSS) and another within the third intron at +49.0 kb from the 
TSS (Fig. 2.5). There was no signal within the second intron at +39.0 kb from the TSS where no 
T3RE was predicted (negative control region).  
       In Neuro2a[TRβ1] cells I found enrichment of TR ChIP signal at the +30.1 kb, but not at the 
+49.0 kb region (Fig. 2.5). Chromatin immunoprecipitation assays for histone 3 (H3) and 
acetylated H3 (AcH3) showed that T3 treatment reduced H3 and increased AcH3 at the +30.1kb 
region (Supplemental Fig. 2.5). Treatment with T3 did not alter H3 signal, but increased AcH3 at 
the +39.0kb and +49.0kb regions (Supplemental Fig. 2.5). These data support that the +30.1 kb 
site is a bona fide T3RE in N2a[TRb1] cells, and that the increased AcH3 signals at +39.0 and 
+49.0 kb may indicate spreading of histone acetylation across the locus initiated by T3-TR action 
at the +30.1 kb T3RE.  
Computer analysis identified seven putative DR+4 T3REs within a 500 bp region 
centered at +30.1 kb from the TSS of the mouse Dnmt3a gene (see Supplemental Fig. 2.6 for 
location of these predicted T3REs). Competitive EMSA showed that radioinert duplex 
oligonucleotides with sequences of predicted T3REs #2, 3, 4 (within a single oligonucleotide 
because these T3REs overlap) and #6 displaced TRβ-RXRα heterodimers from the radiolabeled 
probe; predicted T3REs #1, 5 and 7 did not compete for binding (Fig. 2.6A). I next tested 




transient transfection-reporter assays in Neuro2a[TRβ1] cells, using a luciferase reporter 
construct into which I sub-cloned a 500 bp fragment centered at +30.1 kb from the TSS of the 
mouse Dnmt3a gene. Treatment with T3 for 5 hr induced ~50 fold increase in luciferase activity 
in cells transfected with the construct containing the native DNA sequence (Fig. 2.6B). Single 
base mutations introduced into each of the two half sites of the predicted T3REs 2, 3 and 4 
reduced T3-dependent transactivity by ~2 fold; whereas, mutation of the predicted T3RE #6 
almost completely abolished transactivity (1.4-fold increase relative to control) (Fig. 2.6B). 
Competitive EMSA showed that radioinert genomic fragments that encompass these predicted 
T3REs displaced TRβ-RXRα heterodimers from the radiolabeled probe; however, mutation of 
predicted the T3RE #6 within the fragment abolished its ability to displace the probe 
(Supplemental Fig. 7A). Taken together, the data support a predominant role for the T3RE #6 at 
the +30.1 kb region of the mouse dnmt3a gene. 
 Computer analysis identified a single DR+4 T3RE within a 500 bp region centered at +49.0 
kb from the TSS of mouse Dnmt3a. This T3RE sequence was able to bind TRβ-RXRα 
heterodimers in vitro (Fig. 2.6C) and also supported T3-dependent transactivation in transient 
transfection reporter assays in Neuro2a[TRβ1] cells, which was reduced by single base 
mutations introduced into each of the two half sites of the predicted T3RE (Fig. 2.6D). 
Competitive EMSA showed that radioinert duplex oligonucleotides with the native sequence of 
the +49.0 kb T3RE completely displaced TRβ-RXRα heterodimers from the radiolabeled probe, 
while the mutant sequence caused partial displacement (Supplemental Fig. 7B). 
 
The mouse Dnmt3a T3REs are highly conserved among mammalian species 




vertebrate taxa including mouse but found no clear orthology. However, I found strong sequence 
conservation of both mouse T3REs (+30.1 and +49.0) among eutherian mammals (Supplemental 
Fig. 8). The mouse +49.0 kb T3RE is also present in a metatherian, the wallaby, and in a 
monotreme, the platypus (Supplemental Fig. 8B). However, I found no sequence conservation of 
these mammalian Dnmt3a T3REs in a bird (chicken) or in reptiles (lizard, alligator and turtle). 
 
Discussion 
Thyroid hormone plays a crucial role in normal neurological development. While TR 
regulation of gene transcription via posttranslational modifications of histones is well known (9), 
a potential role for TH modulation of DNA methylation has received little attention. Here I show 
that transcription of a gene that codes for a key enzyme controlling DNA methylation, Dnmt3a, 
is directly regulated by liganded TR in neural cells in the developing brains of frog and mouse. 
Although the frog and mouse T3REs do not appear to be orthologous, I found strong 
conservation of the Dnmt3a T3REs among mammalian species. To my knowledge, this is the 
first report that TRs directly regulate transcription of a gene that influences DNA methylation in 
the central nervous system.  
 
Hormonal regulation of Dnmt3a in the developing brain and identification of T3 response 
elements associated with the gene 
I found that dnmt3a mRNA could be induced in premetamorphic Xenopus tadpole brain 
by treating them with T3 added to the aquarium water. Also, dnmt3a mRNA increased in tadpole 
brain (diencephalon) during spontaneous metamorphosis, with peak expression at metamorphic 




mRNA was widely expressed throughout the tadpole brain, but it was notably excluded from the 
neurogenic regions (the VZ and SVZ) where neural stem cells (NSCs) proliferate. In tadpole 
brain the rate of cell proliferation in the VZ/SVZ peaks at mid-prometamorphosis, then declines 
through late prometamorphosis and metamorphic climax (12). Because this developmental 
decline of cell proliferation inversely correlates with increase in dnmt3a mRNA in tadpole brain, 
DNMT3a may play a role in regulation of cell proliferation in the neurogenic region of the 
developing brain through regulation of cell cycle. In support of this, a recent microarray analysis 
conducted on NSCs derived from the SVZ of Dnmt3a knockout mice showed impaired 
neurogenesis in response to a differentiation signal accompanied by dysregulation of cell cycle 
genes (7). Further work is required to determine whether T3 induces methylation changes at 
promoters regions of cell cycle control gene. 
I further investigated whether Xenopus dnmt3a was a direct TR target gene in the 
developing tadpole brain. Using ChIP, gel shift, mutagenesis and transfection-reporter assays, I 
identified and characterized two functional DR+4 T3REs associated with the Xenopus dnmt3a 
locus: one located at +7.4 kb (T3RE-A) and the other at +4.7 kb (T3RE-B) from the predicted 
translation start site. The third putative TR binding site at the dnmt3a locus (region C) identified 
by TR ChIA-PET on tadpole tail fin (L. Sachs and N. Buisine, unpublished data) was not bound 
by TR in tadpole brain. This may reflect tissue-specific differences in TR binding sites at the 
dnmt3a locus. Because I only investigated TR association in tadpole brain targeting putative TR 
binding sites identified in tadpole tail fin, it is possible that there are more T3REs associated with 





While my evidence supports that Xenopus dnmt3a is a direct TR target gene, treatment of 
late prometamorphic tadpoles with the goitrogen methimazole did not reduce dnmt3a mRNA in 
tadpole brain, although this treatment reduceded mRNA for another known direct TR target 
(klf9) gene. This may suggest that while dnmt3a mRNA is initially induced by TH during early 
stages of metamorphosis, the maintenance of its expression may be independent of T3 during 
later developmental stages. It is also possible that the lack of goitrogen effect on the dnmt3a gene 
may be related to how strongly these two genes are regulated by TH. Developmental increase in 
klf9 mRNA during metamorphosis is very robust (40-50 fold) and the kinetics of its induction in 
premetamorphic tadpole brain is rapid with exogenous T3 treatment (upregulated by 6 hr). By 
contrast, I observed a relatively small developmental increase in dnmt3a mRNA (2-3 fold) 
during metamorphosis, and the kinetics of induction in premetamorphic tadpole brain is slow 
with T3 treatment (upregulated by 24 hrs). Because my goitrogen treatment did not even cause a 
strong reduction for klf9 mRNA (~2-fold), it is possible that my experiment was not sensitive 
enough to detect the effect of goitrogen on weakly regulated genes, such as dnmt3a.     
Given the strong developmental and T3-dependent regulation of dnmt3a in Xenopus brain, 
and previous work showing a parallel increase in circulating plasma [T3] and [T4] with Dnmt3a 
mRNA and protein in mouse brain (4,21-23) (Supplemental Fig. 2.4), I hypothesized that T3 
regulation of this gene is conserved in other vertebrate animals and tested this hypothesis using 
mouse brain and in mouse-derived neuroblastoma Neuro2a[TRβ1] cell line. I found that T3 
injection of PND6 mice rapidly induced Dnmt3a mRNA in brain. Treating the Neuro2a[TRβ1] 
cells with T3 similarly induced Dnmt3a mRNA with rapid kinetics, and this was resistant to 




I also investigated TR association with the Dnmt3a locus in mouse frontal cortex at 
PND14 based on previous finding that the peak expression of the Dnmt3a gene occurs at this 
developmental time point (4),. I found that TR associated at genomic regions +30.1 and +49.0 kb 
from the TSS of the mouse Dnmt3a gene; the DR+4 T3REs found within each locus supported 
T3-dependent transactivation. Despite that the Dnmt3a gene was similarly regulated in mouse 
brain and in Neuro2a[TRβ1] cells, I found TR association only at the +30.1 kb region in 
Neuro2a[TRβ1] cells unlike in PND14 mouse frontal cortex. This may indicate that TR 
association at the Dnmt3a locus is cell type-dependent. However, since the brain tissue is 
composed of a heterogeneous population of neural cells (i.e. neurons and glia) at distinct stages 
of differentiation, I cannot distinguish if the TR interacts with both T3REs in all neural cell types, 
if TR differentially interacts with one of the two identified T3REs dependent on neural cell types 
(and/or at distinct stages of differentiation), or cell line does not recapitulate what may be 
occurring in vivo, and the absence of TR association at the +49.0 kb locus in Neuro2a[TRβ1] 
cells may be nothing to do with normal physiology.  
 
 
Sequence conservation of Dnmt3a T3REs 
 
The frog T3RE-B and the mouse +30.1 kb T3RE are found within the intron between 
coding exons 1 and 2 of the respective Dnmt3a genes. This could indicate that the two regulatory 
elements arose by descent from a common ancestral sequence. However, comparative genomic 
analysis did not support orthology between these two T3REs. I also did not find orthology 
between the frog T3RE-A and either of the mouse dnmt3a T3REs, or conservation of the two frog 




conserved in any other mammalian and amphibian species. More work is required to understand 
the origin(s) of the amphibian and mammalian Dnmt3a T3REs.   
By contrast, I found strong sequence conservation for both of the mouse Dnmt3a T3REs 
among eutherians. This conservation extended to a metatherian, the wallaby, and to a monotreme, 
the platypus for the +49.0 kb but not the 30.1 kb T3RE. Interestingly, I found that the +49.0 kb 
T3RE is a direct repeat plus four base spacer (DR+4) in the genomes of mouse, rat and Chinese 
hamster, while it is DR+5 in other species (Supplemental Fig. 8B). I estimate that the transition 
from DR+5 to DR+4 occurred at least 44 million years ago, since the T3RE sequence is DR+4 in 
Chinese hamster, while it is DR+5 in kangaroo rat and naked mole rat (Supplemental Fig. 8). 
Previous work has shown that DR+5 T3REs can bind TRβ-RXRα heterodimers in vitro, but 
whether they can support T3-dependent transactivation may be dependent on the DR+5 sequence 
context and/or cell types used to test activity, as one study found support for T3-dependent 
transactivity while the other did not (25,26). Further investigation is required to determine 
whether the DR+5 T3RE at the +49.0 kb region of the mouse Dnmt3a locus can support T3-
dependent transactivation. 
Although there is strong conservation of the Dnmt3a T3REs among mammals, my 
analysis did not find similar regulatory elements in birds or reptiles. However, I do not know if 
this is due to divergent, missing or incomplete sequences of genomic regions that could 
potentially contain T3REs in these lineages. I also do not know if the orthologous Dnmt3a genes 
in these two lineages are similarly regulated by TH. Further study is necessary to determine 
when in the evolution of tetrapods the gene came under TH control, whether this evolved once or 




In conclusion, I show that liganded TR directly activates transcription of Dnmt3a genes 
in the developing brains of frog and mouse. This suggests that in addition to modulating 
posttranslational modification of histone, TH can influence global patterns of DNA methylation 
in the developing brain. Therefore, disruption of TH signaling through TH deficiency or 
exposure to endocrine disrupting chemicals during critical periods of brain development could 
impact normal neurological development by interfering with proper establishment of DNA 
methylation by DNMT3a. 
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Fig. 2.1. Dnmt3a mRNA exhibits developmental and T3-dependent increases in Xenopus 
tadpole brain. (A.) I treated premetamorphic (NF stage 50) X. laevis tadpoles with vehicle 
(0.0003% DMSO) or T3 (5 nM) for 6, 24 and 48 hrs and measured dnmt3a mRNA in tadpole 
brain using real-time RT-qPCR. Dnmt3a mRNA is normalized to a reference gene alpha-actinin 
mRNA that did not change with T3 treatment. Points represent the means ± SEM (n=5-6/time 
point/treatment), and asterisks above the means indicate statistically significant increase in 
dnmt3a mRNA compared to 0h time point (1.6-fold at 24 hr; 2.1-fold at 48 hr; F(6,34) = 13.420, p 
< 0.001; ANOVA). Vehicle treatment did not alter the mRNA level at any time point (data not 
shown). (B.) Shown is the dorsal view of Xenopus brain (top) and two transverse sections 
(bottom) at the region of the ventral hypothalamus and thalamic nuclei [1] and the optic tectum 
and tegmentum [2] (bottom). The bolded lines on the transverse sections highlight the ventricular 
and subventricular zones. Abbreviations: P, posterior thalamic nucleus; C, central thalamic 
nucleus; Lpv, lateral thalamic nucleaus, pars posteroventralis; VM, nucleus motorius nervi 
trigemini; NPv, nucleus of the paraventricular organ; VH, ventral hypothalamic nucleus; LH, 
Lateral hypothalamus; tect, optic tectum; Tor, torus semicircularis; tegm, mesencephalic 
tegmentum; Ad, dorsal anterior thalamic nucleus; Av, ventral anterior thalamic nucleus; III, third 
cranial nerve (C.) I treated early prometamorphic (NF stage 54) X. laevis tadpole with vehicle or 
(0.0003% DMSO) or T3 (5 nM) for 48 hrs and conducted ISHH for dnmt3a mRNA (n=3-
4/treatment). Shown are representative photomicrographs of two transverse sections. Scale bars 
= 160 µm. (D.) I measured dnmt3a mRNA using real-time RT-qPCR at different developmental 
stages of X. laevis metamorphosis in brain regions that contained the hypothalamic area and the 
pituitary. Dnmt3a mRNA is normalized to alpha-actinin mRNA that did not change across 
development. Points represent the means ± SEM (n=5/developmental stage), and the letters 
above the means indicate statistically significant differences across developmental stages (means 
with the same letter are not significantly different) (F(4,20) = 3.963, p = 0.017; ANOVA). (E.) I 
conducted ISHH for dnmt3a mRNA on X. laevis tadpole brain harvested at different 
developmental stages of metamorphosis. Shown are representative photomicrographs of two 
transverse sections. Sense probes did not give signals above background (Supplemental Fig. 1). 
For region [1] scale bars = 160 µm for NF stages 52 and 59, 200 µm for NF stages 62 and 66; for 







Fig. 2.2. The TRs associate with the Xenopus dnmt3a locus in tadpole brain. The schematic 
diagram (top) shows location of X. tropicalis dnmt3a coding exons (arrows; up to third coding 
exons) and putative TR binding sites identified by a ChIA-PET experiment conducted on X. 
tropicalis tail fin chromatin (L. Sachs and N. Buisine, unpublished data) (black rectangles; 
regions A, B and C) (distance between features are in kb). I conducted targeted ChIP assays for 
TR at regions A, B and C using brain chromatin isolated from premetamorphic X. laevis tadpoles 
(NF stage 50) treated with vehicle (0.0003% DMSO) or T3 (5 nM) for 48 hrs, and brain 
chromatin from tadpoles at metamorphic climax (NF stage 62). Bars represent the mean ± SEM 
ChIP signal expressed as a percentage of input for TR serum (anti-TR) or normal rabbit serum 
(NRS; negative control) (n=4/group). Asterisks indicate statistically significant enrichment of TR 










Fig. 2.3. Predicted T3REs at the Xenopus dnmt3a locus bind TR-RXR heterodimers in vitro 
and support T3-dependent transactivation. (A.) I conducted EMSA using [32P]-labeled 
oligonucleotide probes corresponding to X. tropicalis dnmt3a xT3RE-A1 and xT3RE-B2 
sequences (Supplemental Table 2.2) and in vitro synthesized Xenopus TRβ plus RXRα. In vitro 
synthesized luciferase was used as a negative control. The arrow indicates the location of 
supershifted bands due to TRifted  binding to the probes. (B.) I tested for transactivity of 
genomic fragments corresponding to X. tropicalis dnmt3a regions A (281 bp) and B (322 bp) in 
transient transfection assays using Neuro2a[TRβ1] cells. After transfection I treated cells with 
vehicle (0.1% DMSO) or T3 (30 nM) for 24 hrs before dual luciferase assay. These genomic 
fragments supported T3-dependent transactivity, which was abolished by single base mutations 
introduced into each of the two half sites of xT3RE-A1 and xT3RE-B2. Bars represent the mean 
fold change in corrected luciferase activity (see Materials and Methods) relative to vehicle-
treated group (normalized to 1; n=4/treatment). Asterisks indicate statistically significant 









Fig. 2.4. Dnmt3a mRNA is induced by T3 with rapid kinetics in mouse neuroblastoma cells. 
(A.) I treated Neuro2a[TRβ1] cells with vehicle (0.1% DMSO) or T3 (30 nM) for 2, 6, 12 and 24 
hrs and measured Dnmt3a mRNA. Points represent means ± SEM, and asterisks above the means 
indicate statistically significant increase in Dnmt3a mRNA compared to 0 hr time point 
(n=4/treatment/time point) (F(8, 25) = 103.017, p < 0.001; ANOVA). Vehicle treatment did not 
alter Dnmt3a mRNA level at any time point (data not shown). (B.) I pre-treated Neuro2a[TRβ1] 
cells with the protein synthesis inhibitor cyclohexamide (CHX; 10 µg/ml) for 1 hr and then 
treated them with vehicle (0.1% DMSO) or T3 (30 nM) for additional 6 hrs in the continuing 
presence or abosence of CHX. Bars represent means ± SEM, and letters above the means 
indicate statistically significant differences among treatments (n = 4/treatment) (F(3,12) = 186.490, 
p < 0.001; ANOVA). For all experiments, I measured Dnmt3a mRNA using real-time RT-qPCR 
and it was normalized to GAPDH mRNA that did not change across development or among 







Fig. 2.5. The TRs associate with the mouse Dnmt3a locus. The schematic diagram (top) shows 
putative TR binding sites (rectangles) identified by TR ChIP-seq experiments conducted on 
mouse liver (REF) and C17.2 mouse cerebellar cell line (REF) that are located between exons 2 
and 4 (arrows) of the mouse Dnmt3a gene (distance between features are in kb). I conducted 
targeted ChIP assays for TR at +30.1, +39.0 and +49.0 kb from the TSS of the mouse Dnmt3a 
gene using chromatin isolated from frontal cortex of PND14 mouse that had received 
intraperatoneal injection of T3 (25 µg/kg BW) four hrs before sacrifice (n=5/treatment). I also 
conducted similar ChIP assays for TR using chromatin isolated from Neuro2a[TRβ1] cells 
treated with T3 (30 nM) for 24 hrs before harvest (I obtained similar results using chromatin from 
Neuro2a[TRβ1] cells treated with vehicle (0.1% DMSO); data not shown). Bars represent the 
mean ± SEM ChIP signal expressed as a percentage of input for TR serum (anti-TR) or normal 
rabbit serum (NRS; negative control). The asterisks indicate significant enrichment of TR ChIP 









Fig. 2.6. Predicted T3REs at the mouse Dnmt3a locus bind TR-RXR heterodimers in vitro 
and support T3-dependent transactivation. (A.) I conducted competitive EMSA using a [32P]-
labeled oligonucleotide probe corresponding to X. tropicalis dnmt3a xT3RE-B2 and radioinert 
duplex oligonucleotides with the sequences of seven putative T3REs found within the region 
located +30.1 kb from the transcription start site (TSS) of the mouse Dnmt3a gene (see 
Supplemental Fig. 7 for location of the predicted T3REs; positions #2, 3 and 4 overlap, so I 
synthesized a single oligonucleotide that encompasses these three predicted T3REs; 
oligonucleotide sequences are given in Supplemental Table 2.2). Before gel electrophoresis the 
probe was incubated with in vitro synthesized Xenopus TRβ plus RXRα with or without 
radioinert oligonucleotides (1 mM). The arrow indicates the location of supershifted bands due to 
TRβ-RXRα binding to the probe. Radioinert oligonucleotides corresponding to T3REs #2-4 and 
6 completely displaced TRβ-RXRα binding to the probe, while those for T3REs #1, 5 and 7 had 
no activity. (B.) I tested for transactivity of a 500 bp genomic fragment centered at +30.1 kb 
from the TSS in transient transfection assays using Neuro2a[TRβ1] cells. After transfection I 
treated cells with vehicle (0.1% DMSO) or T3 (30 nM) for 5 hr before dual luciferase assay. This 
fragment supported T3-dependent transactivity, which was reduced by mutations introduced into 
T3REs #2, 3 and 4, and was almost completely abolished by mutation of T3RE #6 (p = 0.02). 
Bars represent the mean fold change in firefly luciferase activity normalized to Renilla luciferase 
activity relative to vehicle-treated controls (normalized to 1; n=3/treatment) (C.) I conducted 
EMSA using a [32P]-labeled oligonucleotide probe corresponding to the mouse +49.0 kb T3RE 
sequence (Supplemental Table 2.2) and in vitro synthesized Xenopus TRβ plus RXRα. In vitro 
luciferase protein was used as a negative control. The arrow indicates the location of the 
supershifted band due to TRβ-RXRα binding to the probe. (D.) I tested for transactivity of a 500 
bp genomic fragment centered at +49.0 kb from the TSS in transient transfection assays using 
Neuro2a[TRβ1] cells. After transfection I treated cells with vehicle (0.1% DMSO) or T3 (30 nM) 
for 24 hr before dual luciferase assay. This fragment supported T3-dependent transactivity, which 
was reduced by mutation of single predicted T3RE located in this region. Bars represent the mean 
fold change in corrected firefly luciferase activity normalized to vehicle-treated controls 
(normalized to 1; n=4/treatment). Asterisks indicate statistically significant differences between 





DEVELOPMENTAL AND T3-DEPENDENT DNA DEMETHYLATION IN XENOPUS 
TADPOLE BRAIN DURING METAMORPHOSIS 
 
Abstract 
Methylation of cytosine in DNA (DNA methylation) is an epigenetic modification that 
plays a critical role during postembryonic neurological development. I used Xenopus tadpole 
metamorphosis, a thyroid hormone (T3)-dependent postembryonic developmental process, to 
investigate roles for DNA methylation in gene regulation, and its possible regulation by T3. 
Using three independent biochemical assays I saw a progressive decline in whole genome DNA 
methylation in tadpole brain during metamorphosis, which correlated with increases in mRNAs 
for genes that code for enzymes that catalyze DNA demethylation (tet2, tet3, apobec2, gadd45β, 
gadd45γ and tdg). Treatment of premetamorphic tadpoles with T3 induced tet3, gadd45γ and tdg 
mRNAs in the brain. Using methylation-sensitive restriction digest followed by PCR, I found 
that genomic regions with T3
 
response elements (T3REs) associated with known T3-response 
genes (klf9 and dnmt3a) became demethylated during metamorphosis, which correlated with 
developmental increases in their mRNAs. Furthermore, T3
 
treatment of premetamorphic tadpoles 
induced DNA demethylation at these loci. In vitro methylation of DNA fragments containing the 
T3REs subcloned into reporter plasmids abrogated T3-dependent transactivation. My findings 
support that T3
 
regulates DNA methylation in the tadpole brain during metamorphosis, and that 
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 DNA Methylation at carbon-5 position of cytosine (5-methylcytosines; 5-mC) is a critical 
epigenetic modification that controls gene expression. In vertebrate genomes 5-mC is 
predominantly found in the context of cytosine-guanine (CpG) dinucleotides, although recent 
research has shown that CpH (where H = A, T, and C) methylation is also present in the genome 
of embryonic stem cells and neural cells (1-4). The dynamics of genome-wide DNA methylation 
patterns (the methylome) are regulated by DNA methyltransferases (DNMTs: DNMT1, 
DNMT3a and DNMT3b) that methylate cytosines, and by enzymes that remove 5-mC to 
demethylate DNA. Active DNA demethylation is initiated by the ten-eleven translocation (TET) 
enzymes that oxidize 5-mC to 5-hydroxymethylcytosine (5-hmC) (5); the 5-hmC is then 
removed by two different pathways to complete the process of DNA demethylation. For example, 
5-hmC can be de-aminated to unmethylated cytosine by the combined actions of activity-induced 
cytidine deaminase (AID) and the apolipoprotein B mRNA editing enzyme, catalytic polypeptide 
(APOBEC) (6). Alternatively, 5-hmC can be further oxidized by TET enzymes to 5-
formylcytosine (5-fC), then to 5-carboxylcytosine (5-caC) (7,8) and removed through the base-
excision repair pathway catalyzed by thymine DNA glycosylase (TDG), or by nucleotide 
excision repair pathways catalyzed by growth arrest and DNA damage (GADD45) enzymes (6).  
 During mammalian embryogenesis global changes in DNA methylation occur in pre-
implantation zygotes and in primordial germ cells to establish X-chromosome inactivation, 
monoallelic expression of imprinted genes and tissue-specific patterns of gene expression (9). 
Similar global changes in the met(2)hylome have been reported during embryogenesis of other 
vertebrates such as Xenopus (10). Mounting evidence indicates that dynamic changes in the 
methylome continue beyond embryogenesis, and recent research has highlighted the crucial roles 
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for modulating DNA methylation in postembryonic maturation of the brain. For example, a 
recent comprehensive genome-wide analysis of 5-mC in the developing frontal cortex of human 
and mouse found a dramatic increase in CpA methylation during the early postnatal period that 
coincided with the period of synaptogenesis and synaptic pruning (2). Other studies also showed 
that the 5-hmC abundance increased during the same developmental period in the frontal cortex, 
cerebellum and hippocampus of the mouse brain (2,11,12), indicating that neural cells undergo 
dynamic rearrangement of their methylomes during early postembryonic brain development. 
 In all vertebrates studied, postembryonic development is crucially dependent on thyroid 
hormone (T3). Thyroid hormone exhibits a dramatic increase during the early postnatal period in 
mammals and exerts pleiotropic actions on the developing brain (13-15). The molecular actions 
of T3 are mediated by T3 receptors (TRs) that regulate target gene transcription by recruiting 
histone-modifying enzymes to their binding sites in the genome (T3 response elements; T3RE). In 
addition to this well-known role for posttranslational modification of histones, I recently found 
that TRs regulate transcription of Dnmt3a in the brains of mouse and Xenopus during 
postembryonic development (Chapter 2), suggesting that T3 may influence key epigenetic 
changes in the developing brain by modulating a key enzyme that methylates DNA.  
 In the present study I investigated developmental and T3-dependent modulation of the 
methylome of neural cells in the developing brain of Xenopus tadpoles during metamorphosis, a 
T3-dependent postembryonic process. I found that the neural cell genome in Xenopus tadpole 
brain exhibited a progressive decline in 5-mC during metamorphosis, which correlated with 
developmental and T3-dependent increases in mRNAs for genes that encode enzymes that 
actively remove 5-mC (tet3, gadd45γ and tdg). I also found that genomic regions that contain 
T3RE s for known T3-response genes (klf9 and dnmt3a) become demethylated in tadpole brain 
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during metamorphosis and in response to exogenous T3. Furthermore, in vitro methylation of 
these genomic loci strongly inhibited T3-dependent transactivity in transient transfection-reporter 
assays, supporting that developmental DNA demethylation may be important for T3-dependent 
transactivation of T3-response genes in the developing brain. My findings support that T3 
modulates the methylome of neural cells in the developing brain during postembryonic 
development. 
 
Materials and Methods 
Animal care and thyroid hormone (T3) treatment of Xenopus tadpoles 
Xenopus laevis and X. tropicalis tadpoles were obtained by in-house breeding, reared in 
dechlorinated tap water (water temperature, 21 – 23 °C for X. laevis; 23 – 25 °C for X. tropicalis), 
maintained at 12L:12D photoperiod and fed ad libitum with pulverized frog brittle powder 
(NASCO, Fort Atkinson, WI). The normal table of Nieuwkoop and Faber (NF) (1994) was used 
to assign developmental stages.  
I placed premetamorphic X. laevis tadpoles (NF stage 50) in aquaria containing two liters 
of water 24 hr prior to hormone treatment. Thyroid hormone (3,5,3′-L-triiodothyronine; T3 
sodium salt; Sigma-Aldrich, St. Louis, MO) was first dissolved in dimethylsulfoxide (DMSO) 
and directly added to the aquarium water. I treated animals with vehicle (0.0003% DMSO) or T3 
(1.5 or 5 nM) for different times before harvest. Twenty-four hours after hormone treatment was 
initiated, the water was exchanged and T3 was replenished. Tadpoles were killed by rapid 
decapitation, whole brains were dissected, and either snap frozen in liquid nitrogen and stored at 
–80 °C until RNA or genomic DNA extraction. 
All procedures involving animals were conducted in accordance with the guidelines of 
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the University Committee on the Care and Use of Animals of the University of Michigan. 
 
Enzyme-linked immunosorbent assay (ELISA) 
 I pooled 20 X. laevis tadpole brains for NF stage 48 for each biological replicate, 15 for NF 
50, 10 for NF 54, 2 for NF stages 58 and 62, and extracted genomic DNA using the DNeasy 
Blood and Tissue kit (Qiagen, Valencia, CA). I measured the abundance of 5-mC in 150 ng of 
input genomic DNA using MethylFlash Methylated DNA Quantification Kit (Epigentek, 
Farmingdale, NY). A relative quantification method was used to compare the abundance of 5-
mC across developmental stages by generating a standard curve with known amounts of 5-mC. 
For each biological sample I averaged the quantity of two technical replicates. 
 
Luminometric Methylation Assay (LUMA) 
 I conducted LUMA assay as described by Karimi et al. (2006) (16) with modifications. 
More detail method is described in Head et al. (2014) (17). I extracted genomic DNA using the 
DNeasy Blood and Tissue kit (Qiagen) from whole brain of premetamorphic (NF stage 50) X. 
laevis tadpole treated with vehicle (0.0003% DMSO) or T3 (5 nM) for 48 hrs, and from whole 
brain of untreated X. laevis tadpole at metamorphic climax stage (NF stage 62). For each 
biological replicate I pooled brains from 15 animals for NF stage 50 and 2 animals for NF stage 
62. I digested 300 ng of input DNA with either HpaII or MspI (isoschizomers that recognize 
CCGG; HpaII is sensitve to CpG methylation while MspI is insensitive) for 4 hrs at 37 °C. I 
quantified the extent of restriction digest using pyrosequencing.  
 
Cytosine Extension Assay 
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 I conducted Cytosine Extension Assay as described by Pogribny et al. (1999) (18) with 
modifications. I digested 1 µg of genomic DNA with 10 units of either HpaII or MspI 
isoschizomers (NEB) at 37 °C overnight. I then incubated 200 ng of the digested DNA in 25 µL 
reaction with [32P]dCTP (10 µCi) and GoTaq DNA polymerase (1U) at 56 °C for 1 hr. I applied 
10 µl sample of the reaction to a piece of Whatman DE-81 ion-exchange filter, and then washed 
it three times with 0.5M sodium phosphate buffer (pH = 7) at room temperature. I air-dried the 
filter and measured incorporated radioactivity using scintillation counting, which was normalized 
to the total radioactivity measured from 2.5 µl of the fill-in reaction.  
 
RNA extraction and reverse transcriptase real-time quantitative PCR (RT-qPCR) 
I extracted total RNA from whole tadpole brain using TRIZOL reagent (Invitrogen Life 
Technologies, Carlsbad, CA). Prior to cDNA synthesis, I treated the total RNA with 20 units of 
deoxyribonuclease I (DNAse I) (Invitrogen) in the presence of RNAse inhibitor (Roche Applied 
Sicence, Indianapolis, IN). I reverse transcribed cDNA using the High Capacity cDNA Synthesis 
Kit (Applied Biosystems Inc. (ABI), Foster City, CA). I conducted real-time qPCR using 
ABsolute Blue qPCR SYBR Low ROX Mix (ABgene Thermo Scientific, Surrey, UK) and Fast 
7500 Real-Time PCR System (ABI) or StepOne Real Time PCR Systems (Life Technologies). I 
designed primers to span exon/exon boundaries for the following X. laevis genes: tet2, tet3 
(Genbank Accession# HQ220208), apobec2 (Genbank Accession# NM_001092842.1), apobec4, 
gadd45α (Genbank Accession# NM_001086068.1), gadd45β, gadd45γ (Genbank Accession# 
NM_001090459.1), TDG (Genbank Accession# NM_001090821.1), AID (Genbank Accession# 
NM_001095712.1); and X. tropicalis klf9 (Genbank Accession# NM_001113674.1) and dnmt3a 
(Genbank Accession# XM_002942354.2) (see Supplemental Table 1 for primer sequences). A 
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relative quantification method (19,20) was used to compare gene expression levels across 
developmental stages or among treatments by generating standard curves for each gene with a 
pool of cDNAs. All mRNAs were normalized to alpha-actinin mRNA (NM_001090829.1 for X. 
laevis, NM_001079198.1 for X. tropicalis) that did not change across development or with T3 
treatment. 
 
Methylation-sensitive restriction digest followed by qPCR (chop-qPCR) 
 I extracted genomic DNA from tadpole brain using DNeasy Blood and Tissue Kit (Qiagen). 
For X. laevis tadpoles I extracted genomic DNA from whole brain; for X. tropicalis I extracted 
DNA from the microdissected region of the diencephalon that contained the hypothalamus and 
the pituitary. I incubated 1 µg of genomic DNA in a 50 µl reaction with 10 units of Hinp1I 
(NEB) at 37 °C overnight, purified DNA using phenol/chloroform/isoamyl alcohol (Invitrogen, 
Life Technologies, Carlsbad, CA) and resuspended in 40 µl of buffer AE (Qiagen, 10mM Tris, 
0.5mM EDTA, pH 9.0). To measure the extent of restriction digest, I conducted genomic DNA 
qPCR using primers that flank the restriction sites (see Supplemental Table 1 for primer 
sequences) and normalized the quantity of amplification to genomic regions that did not contain 
the restriction sites. 
 
Intracerebroventricular (i.c.v.) injection of 5-aza-2’-deoxycytidine into Xenopus tadpole 
brain 
 The DNMT inhibitor 5-aza-2’-deoxycytidine (5-aza-2’-dC; Sigma-Aldrich) was first 
dissolved in 0.6% saline to a final concentration of 10 mM. I first anesthetized premetamorphic 
(NF stage 50) X. laevis tadpoles by immersing them in 0.002% benzocaine and then administered 
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i.c.v. microinjection of vehicle (0.6% saline) or 5-aza-2’-dC into the third ventricle of tadpole 
brain (110 nl). Both solutions contained 0.02% Fast Green dye as a tracing marker. 
 
Plasmid constructs 
I subcloned DNA fragments corresponding to the sequences of genomic regions that 
encompassed X. tropicalis klf9 (179 bp) and dnmt3a (322 bp) T3REs into the CpG-less luciferase 
reporter vector (pCpGL; gift of Michael Rheli) at the BglII and HindIII sites. I in vitro 
methylated or mock-treated these plasmids in a 100 μl reaction by incubating them with 10 units 
of M.SssI CpG methyltransferase (NEB) and SAM substrate (640 uM) for eight hrs; I 
replenished SAM four hrs into reaction. I purified the plasmids using phenol/chloroform/isoamyl 
alcohol precipitation (Invitrogen) and resuspended them in 25 μl of buffer EB (Qiagen; 10 mM 
Tris, pH = 8.5). I verified that in vitro methylation prevented Hinp1I restriction digest (NEB; 10 
units per reaction) (data not shown). 
 
Cell culture and transient transfection assays 
I cultured Neuro2a[TRβ1] cells (21) as previously described (22) in DMEM/F12 
containing 10% fetal bovine serum that had been stripped of thyroid hormone (23) and was 
supplemented with hygromycin B (500 µg/ml). I plated cells at a density of 0.15 X 106 per well 
in 24-well plates. When cells had reached 60-70% confluency, I transfected cells with luciferase 
reporter constructs (described above; 200 ng per well plus 10 ng pRenilla-tk) using FuGene 6 
transfection reagent (Promega, Madison, WI). Twenty-four hr after transfection I treated cells 
with vehicle (0.1% DMSO) or T3 (30 nM) for 24 additional hrs before harvest for analysis by 




Electrophoretic mobility shift assays (EMSA) 
 
I conducted EMSA as previously described by (24). Xenopus TRβ and retinoid X 
receptor alpha (RXRα) proteins were in vitro synthesized using pSp64a-TRβ and pSp64a-RXRα 
plasmids (gift of Yun-Bo Shi) and the TnT SP6 Quick-Coupled Translation System (Promega). 
I conducted competitive EMSA using radioinert double-stranded DNA fragments 
encompassing the T3RE regions for X. tropicalis klf9 (~180 bp) or dnmt3a (~320 bp) genes. To 
synthesize methylated competitors, I first in vitro methylated the pCpGL constructs containing 
these genomic fragments (see above) by incubating them with M.SssI CpG methyltransferases as 
described above. I then released the inserts with restriction digest (BamHI and HindIII) and gel 
purified the fragments. I verified successful in vitro methylation of these genomic fragments 
based on resistance to Hinp1I restriction digest, which is sensitive to CpG methylation 
(Supplemental Fig. 3.1). 
 
Data analysis and statistics  
I analyzed data using SPSS statistical software (version 19; SPSS Inc., Chicago, IL). I 
conducted one-way ANOVA followed by Fisher’s least significant difference (Fisher’s LSD) 
post hoc test and Student’s independent sample t-test (α=0.05). Data were Log10-transformed 






The neural cell genome in Xenopus tadpole brain becomes demethylated during 
metamorphosis, which correlated with developmental and T3-dependent increases in 
expression of genes involved with DNA demethylation 
 Using enzyme-linked immunosorbent assay (ELISA) I found that the amount of 5-
methylcytosine (5-mC) in the neural cell genome of X. laevis tadpole brain remained unchanged 
from premetamorphosis to early prometamorphosis (NF stages 48 to 54), declined during late 
prometamorphosis (NF stage 58) and reached its lowest level at metamorphic climax (NF stage 
62) (Fig. 3.1A). I confirmed this reduction in whole genome DNA methylation using two other 
independent assays, cytosine extension assay (18) and luminometric methylation assay (LUMA; 
(16)). These two assays showed that the neural cell genome in X. laevis tadpole brain was less 
methylated at metamorphic climax (NF stage 62) than during premetamorphosis (NF stage 50) 
(Table 1).  
 Given the large decrease in 5-mC occurring in tadpole brain during metamorphosis, I 
hypothesized that genes that encode enzymes that catalyze DNA demethylation would show 
correlated changes in expression during metamorphosis. Using real-time RT-qPCR I found that 
tet2 and tet3 mRNAs increased in X. laevis tadpole brain between premetamorphosis and early 
prometamorphosis (NF stage 50 to 54), remained elevated until metamorphic climax (NF stage 
62) and then declined to basal level at the end of metamorphosis (NF stage 66) (Fig 1B). The tdg 
and apobec2 mRNAs showed similar developmental profiles as tet2 and tet3 mRNAs (Fig. 3.1B). 
The gadd45β mRNA exhibited basal expression between premetamorphosis and metamorphic 
climax, and increased at the end of metamorphosis. By contrast, the gadd45γ gene exhibited 
elevated expression during earlier stages of metamorphosis between premetamorphosis and late 
prometamorphosis and declined towards the end of metamorphosis (Fig. 3.1B). The gadd45α 
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mRNA did not show changes during metamorphosis, and AID mRNA was undetectable 
throughout metamorphosis (data not shown). I also found that treating premetamorphic (NF 
stage 50) X. laevis tadpoles with exogenous T3 added to the aquarium water (5 nM) caused time-
dependent increases in tet3, gadd45γ and tdg mRNAs in tadpole brain as analyzed by real-time 
RT-qPCR (Fig. 3.1C); the same treatment did not change tet2, apobec2 and gadd45β mRNA 
levels (data not shown).  
 
Thyroid hormone response elements (T3REs) for known T3-regulated genes become 
demethylated in tadpole brain during metamorphosis, which correlated with increases in 
the mRNA levels of the regulated genes  
 A recent study analyzed genome-wide changes in DNA methylation during X. tropicalis 
gastrulation using methylated DNA capture (MethylCap) followed by high-throughput 
sequencing (MethylCap-seq) (25). By analyzing their dataset I found that genomic regions that 
contain T3REs for the Krüppel-like factor 9 (klf9) and dnmt3a genes overlapped with regions that 
are enriched for DNA methylation (Supplemental Fig. 3.2). Because these T3REs are important 
for T3-dependent transactivation of klf9 and dnmt3a genes ((22); Chapter 2), I investigated 
whether these loci might exhibit changes in DNA methylation in tadpole brain during 
metamorphosis.  
 I conducted chop-qPCR analysis targeting klf9 and dnmt3a T3RE regions in X. tropicalis 
tadpole brain and found that both regions became demethylated during metamorphosis (Fig. 
3.2A). Both loci became demethylated between early and mid-prometamorphosis (NF stages 54 
and 56) and stayed demethylated throughout the rest of metamorphosis until its completion; the 
dnmt3a T3RE region reached its lowest methylation level at the end of metamorphosis (NF stage 
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66) (Fig. 3.2A). Homologous loci in the X. laevis genome were also less methylated at 
metamorphic climax (NF stage 62) than during premetamorphosis (NF stages 52) as analyzed by 
chop-qPCR (Supplemental Fig. 3.3). Demethylation of the T3RE regions correlated with 
increases in klf9 and dnmt3a mRNAs as analyzed by RT-qPCR (Fig. 3.2B). I also conducted 
MethylCap assay targeting these two genomic loci and confirmed DNA demethylation at the 
dnmt3a T3RE region; however, this assay did not detect methylation changes around the klf9 
T3RE region likely due to differences in sensitivity of the two assays (Fig. 3.2C). Chop-qPCR 
assay analyzes the methylation state of a single CpG site (high resolution), while the MethylCap 
assay surveys the methylation state of multiple CpG dinucleotides around the target region, the 
resolution of which is determined by the fragment size of sonicated DNA (low resolution). Also, 
since I conducted qPCR assay on high-salt fraction of MethylCap assay eluate, this may indicate 
that the klf9 T3RE region is barely methylated (based on the scale of % recovery relative to input 
samples).  
 In a first attempt to investigate whether T3 can induce changes in DNA methylation in 
tadpole brain, I treated premetamorphic (NF stage 50) X. laevis tadpoles with exogenous T3 (5 
nM) for 48 hrs. However, this treatment regimen did not cause DNA demethylation in the whole 
genome as analyzed by 5-mC ELISA and LUMA (Table 1), or at the klf9 and dnmt3a T3RE 
regions using chop-PCR assay (Supplemental Fig. 3.4). However, 48 hr T3 treatment increased 
tet3, gadd45g and tdg mRNAs in tadpole brain (Fig. 3.1C). Therefore, I hypothesized that there 
may be a temporal delay in DNA demethylation in the genome after mRNAs for DNA 
demethylase enzymes increased, and so I conducted another experiment by treating tadpoles for 
a longer period of time (96 hrs) with a lower dose of T3 (1.5 nM) (I used a lower dose of T3 
because tadpoles do not survive beyond three days with the higher dose – 5 nM). I found that 
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treating X. laevis premetamorphic tadpoles with T3 for 96 hr caused DNA demethylation of klf9 
and dnmt3a T3RE regions (Fig. 3.3); I did not investigate whether this treatment caused DNA 
demethylation in the whole genome.  
I also investigated whether the DNMT inhibitor 5-aza-2’-deoxycitidine (10 mM) would 
induce changes in DNA methylation at klf9 and dnmt3a T3RE regions. Four days of daily 
intracerebroventricular injection of 5-aza-2’-deoxycitidine caused demethylation of the dnmt3a 
T3RE region, which was enhanced when combined with T3 (1.5 nM over 4 days; Fig. 3.3). The 5-
aza-2’dC injection alone did not alter DNA methylation at the klf9 T3RE region, and the 
combined treatment did not enhance T3-induced demethylation at this locus (Fig. 3.3). 
  
CpG Methylation impairs T3-dependent transactivation 
 I sublconed DNA fragments corresponding to the klf9 and dnmt3a T3RE regions into the 
CpG-less luciferase reporter plasmid (pCpGL; gift of Michael Rheli), in vitro methylated (or 
mock-treated) them with M.SssI CpG methyltransferase and conducted transient transfection-
reporter assays using Neuro2a[TRβ1] cells. Both DNA fragments supported robust T3-dependent 
transactivity; however, methylating CpG sites within these genomic regions caused a strong 
reduction in transactivity (Fig. 3.4). I hypothesized that this reduction in T3-dependent 
transactivity was due to reduced TR-RXR binding to the klf9 and dnmt3a T3RE regions. 
Competitive EMSA showed that radioinert genomic fragments corresponding to the klf9 and 
dnmt3a T3RE regions displaced TRβ-RXRα from the radiolabeled oligonucleotide probe in a 
concentration-dependent manner (Fig. 3.5). It also showed that the radioinert competitor 
oligonucleotides that had been in vitro methylated at CpG sites displaced TRβ-RXRα in a 





Postembryonic brain development is critically dependent on thyroid hormone. Recent 
work by Lister and colleagues (2) showed dynamic changes in the neural cell methylome during 
the early postnatal period in mouse and human. Here, I found that the neural cell genome of 
Xenopus tadpoles became globally and progressively demethylated during metamorphosis, and 
this correlated with developmental, T3-dependent upregulation of genes involved with active 
DNA demethylation (tet3, gadd45γ and tdg). I also found examples of local DNA demethylation 
at T3RE regions associated with known T3-response genes (klf9 and dnmt3a) during 
metamorphosis and in response to exogenous T3. Furthermore, in vitro methylation of these 
DNA sequences strongly inhibited T3-dependent transactivity. To my knowledge, this is the first 
report showing that T3 modulates the neural cell methylome. My findings support that T3 
modulates DNA methylation to regulate developmental gene expression programs.   
 
Developmental DNA demethylation and regulation of genes that catalyze active DNA 
demethylation in Xenopus tadpole brain during metamorphosis  
I found that the tadpole neural cells became demethylated during metamorphosis. The 
abundance of 5-mC declined by almost 50% between the onset of metamorphosis and 
metamorphic climax, which is a striking reduction given the size of the X. laevis genome to be 
around 3.1 billion base pairs (26). Three independent assays (ELISA, LUMA and cytosine 
extension assay) confirmed DNA demethylation in tadpole brain. The percentage change was 
smaller with LUMA and cytosine extension assays compared with ELISA (Table 1). This is 
likely due to differences in what these three assays measure. While ELISA measures the 
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abundance of 5-mC regardless of the context within which it is found, LUMA and cytosine 
extension assays survey a subpopulation of all 5-mC recognized by MspI/HpaII isoschizomers 
used in these assays. Therefore, the percentage change detected by LUMA and cytosine 
extension assay is likely an underestimate, as methylated cytosines are also present in sequence 
contexts that are not recognized by these restriction enzymes. Furthermore, a recent genome-
wide study of 5-mC in the developing mammalian brains showed CpH methylation exhibited 
more dynamic changes than CpG methylation (2). Future studies should investigate whether 
CpH methylation is also present in the Xenopus genome and whether it exhibits dynamic changes 
in tadpole brain during metamorphosis. 
Because I investigated DNA methylation changes in mixed population of cells in tadpole 
brain, I do not know whether global DNA demethylation occurred uniformly among all types of 
neural cells or within a subpopulation. A previous study showed that the intragenic region (gene 
body) of cell type-specific genes became differentially methylated depending on neural cell type 
(2); therefore, it is likely that subtypes of neural cells in tadpole brain undergo differential 
changes in DNA methylation during metamorphosis.  
Correlated with global DNA demethylation, I also found that mRNAs for genes that are 
involved with active DNA demethylation (tet2, tet3, apobec2, gadd45β, gadd45γ and tdg) 
increased in X. laevis tadpole brain during metamorphosis. Of these six genes, tet3, gadd45γ and 
tdg mRNAs also increased in premetamorphic tadpole brain in response to exogenous T3. 
Developmental and T3-dependent regulation of tet3, gadd45γ and tdg genes in tadpole brain 
suggest roles of these enzymes in postembryonic neurological maturation of the brain. Previous 
study has shown that Xenopus TET3 plays a role in neural cell development during 
embryogenesis through regulation of genes that are involved in neurogenesis (27). Future studies 
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should further investigate whether activity of DNA demethylases increases in tadpole brain to 
catalyze global decrease in 5-mC during metamorphosis. 
 
Developmental and T3-dependent local DNA demethylation at T3RE associated with known T3-
response genes 
The klf9 and dnmt3a T3REs are important for T3-dependent transactivation of the 
associated genes ((22); Chapter 2). I found that these T3RE regions became demethylated in 
tadpole brain during metamorphosis, which correlated with developmental increases in klf9 and 
dnmt3a mRNAs. I also found that T3 treatment of premetamorphic tadpoles precociously induced 
DNA demethylation at these T3REs in tadpole brain. Furthermore, in vitro methylation of CpG 
nucleotides of T3RE regions strongly reduced T3-dependent transactivity, although the sequences 
of klf9 and dnmt3a T3REs themselves do not contain CpG dinucleotides. These findings together 
suggest that developmental DNA demethylation of T3RE regions may be important for 
regulation of their T3-dependent transactivity and thus regulation of T3-response genes in tadpole 
brain during metamorphosis. 
Recent studies have shown that methylated cytosines are also abundantly present in the 
context of CpA dinucleotides in the neural cell genome (2-4), which could be bound by methyl-
CpG binding protein at an equal affinity (MeCP2) (29). Although the sequences of klf9 and 
dnmt3a T3REs do not contain CpG dinucleotides, which may explain why CpG methylation of 
DNA fragments did not alter TRβ-RXRα binding to these sequences (Fig. 3.5), both T3REs 
sequences contain CpA dinucleotides at their respective half-sites. As a preliminary experiment 
to investigate whether CpA methylation inhibits TRβ-RXRα binding, I synthesized DNA 
fragments encompassing the klf9 and dnmt3a T3REs in PCR reactions in which all cytosines 
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became methylated, and then conducted a competitive EMSA using these fragments as radioinert 
competitors to compete for TRβ-RXRα binding with the radiolabeled probe. I found that 
methylated DNA fragments competed less efficiently for TRβ-RXRα heterodimers than 
fragments that were not methylated (Supplemental Fig. 3.5). This result suggests that CpA 
methylation within T3REs could be inhibitory to TR-RXR binding, but this needs further 
investigation whether specifically methylating CpA dinucleotides within the klf9 and dnmt3a 
T3REs alter TR-RXR binding.  
In conclusion, I showed that Xenopus tadpole brain became demethylated during 
metamorphosis and in response to T3, which may be catalyzed by T3 activation of genes that are 
involved with active DNA demethylation. I previously found that T3 also activates the dnmt3a 
gene that codes for enzymes that catalyze DNA methylation (Chapter 2). Findings in the current 
study extended a role for T3 in modulating the neural cell methylome to regulate gene regulation 
programs during postembryonic neurological development. 
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Fig. 3.1. The abundance of 5-methylcytosine in the neural cell genome of Xenopus tadpole 
brain declines during metamorphosis, which correlates with developmental and T3-
dependent increases in expression of genes that are involved in active DNA demethylation. 
(A.) I measured abundance of 5-methylcytosine (5-mC) in the neural cell genome of X. laevis 
tadpole brain at different developmental stages of metamorphosis using enzyme-linked 
immunosorbent assay (ELISA). Points represent the means ± SEM (n=5/developmental stage), 
and letters above the means indicate statistically significant differences across development 
(means with the same letter are not significantly different) (F(4,20) = 36.096, p < 0.001; ANOVA). 
(B.) I measured tet2, tet3, gadd45α, gadd45β, gadd45γ, apobec2, apobec4, AID and TDG 
mRNAs in the region of X. laevis tadpole brain that contained the hypothalamic area and the 
pituitary at different developmental stages of metamorphosis using real-time RT-qPCR. All 
mRNAs were normalized to mRNA for a reference gene (alpha-actinin) that did not change 
across development (Supplemental Fig. 3.1). Points represent the means ± SEM 
(n=5/developmental stage), and the letters above the means indicate statistically significant 
differences across development (means with the same letter are not significantly different) (tet2: 
F(4,20) = 6.742, p = 0.001; tet3: F(4,20) = 10.717, p = 0.001; gadd45β: F(4,19) = 7.867, p = 0.001; 
gadd45γ: F(4,19) = 6.531, p = 0.002; apobec2: F(4,20) = 11.604, p < 0.001; TDG: F(4,19) = 8.928, p < 
0.001; ANOVA). Gadd45α and apobec4 mRNAs did not change during metamorphosis; AID 
mRNA was undetectable in tadpole brain (data not shown). (C.) I treated premetamorphic (NF 
stage 50) X. laevis tadpoles with vehicle (0.0003% DMSO) or T3 (5 nM) for 6, 24 and 48 hrs and 
measured tet2, tet3, gadd45β, gadd45γ, apobec2 and TDG mRNAs in tadpole brain using real-
time RT-qPCR. All mRNAs were normalized to alpha-actinin mRNA that did not change with 
T3 treatment. Points represent the means ± SEM (n=5-6/time point/treatment), and asterisks 
above the means indicate statistically significant increases relative to mRNA levels at 0 hr time 
point (tet3: 1.4-fold at 24 hr; 1.9-fold at 48 hr; F(6,34) = 3.888, p < 0.001; gadd45γ: 1.6-fold at 6 hr, 
3.6-fold at 24 hr; 5.5-fold at 48 hr; F(6,34) = 19.430, p < 0.001; TDG: 2.0-fold at 48 hr; F(6,34) = 
3.816, p < 0.001; ANOVA). Tet2, gadd45β, apobec2 and apobec4 mRNAs did not change with 
T3 treatment; vehicle treatment did not change mRNA levels at any time point (data not shown).
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A. Luminometric Methylation Assay (LUMA) 
 
Stage + treatment % Methylation 
 




91.8 ± 0.2 
 
NF stage 52 
+ T3  (5 nM, 48 hrs) 
 
 
91.9 ± 0.1 
 




90.2 ± 0.2* 
 
B. Cytosine Extension Assay 
 
 % Methylation 
 
NF stage 50 
 
 
90.7 ± 0.2 
 
NF stage 62 
 
 
87.1 ± 0.2* 
 
 
Table 3.1. The genome of cells in Xenopus tadpole brain becomes globally demethylated 
during metamorphosis. I extracted genomic DNA from whole brain of premetamorphic (NF 
stage 50-52) X. laevis tadpole treated with vehicle (0.0003% DMSO) or T3 (5 nM) for 48 hr, and 
untreated tadpole at metamorphic climax stage (NF stage 62). I digested DNA with a pair of 
HpaII/MspI isoschizomers that recognize 5’ – CCGG- 3’ then conducted either LUMA (A) or 
Cytosine extension assay (B) to measure the extent of restriction digest. I did not have T3-treated 
brain sample for analysis. The number represents the mean percentage ± SEM of methylated 
CpG dinucleotides within the HpaII/MspI restriction sites. The asterisk represents statistically 
significant differences in % methylation (LUMA: F(2,12) = 13.733, p < 0.001 ANOVA; Cytosine 








Fig. 3.2. The klf9 and dnmt3a T3REs regions become demethylated in Xenopus tadpole 
brain during metamorphosis, which correlated with developmental increases in their 
mRNAs. (A.) I isolated genomic DNA from the region of X. tropicalis tadpole brain that 
contained the hypothalamic area and the pituitary at different developmental stages of 
metamorphosis, and conducted methylation-sensitive restriction digest/qPCR (chop-qPCR) 
assays targeting genomic regions that contain T3REs for the klf9 and dnmt3a loci (primer 
sequences are given in Supplemental Table 3.1). Amplification of target genomic regions was 
normalized to that of genomic region that did not contain restriction sites. Points represent the 
means ± SEM (n=5/developmental stage), and letters above the means indicate statistically 
significant differences across development (means with the same letter are not significantly 
different) (dnmt3a T3RE: F(5,18) = 35.093, p < 0.001; klf9 T3RE : F(5,18) = 9.847, p < 0.001; 
ANOVA) (n=4/developmental stage). (B.) I also conducted the MethylCap assay on the same X. 
tropicalis genomic DNA samples as described in Fig. 3.2A targeting the klf9 and dnmt3a T3REs 
regions. Bars represent the mean ± SEM signal expressed as a percentage of input. The asterisk 
above the mean indicates statistically significant differences compared to NF stage 50 (p = 0.029, 
Student’s independent sample t-test) (n=4/developmental stage) (C.) I measured klf9 and dnmt3a 
mRNAs in the same brain region of X. tropicalis tadpole brain as in Fig. 3.2A at different stages 
of metamorphosis using real-time RT-qPCR. Both mRNAs were normalized to alpha-actinin 
mRNA that did not change across development. Points represent the means ± SEM 
(n=5/developmental stage), and the letters above the means indicate statistically significant 
differences across development (means with the same letter are not significantly different) (klf9: 






Fig. 3.3. Treating premetamorphic Xenopus tadpoles with exogenous T3 (and/or 5-aza-2’-
deoxycytidine) induces DNA demethylation at klf9 and dnmt3a T3RE regions. I administered 
daily intracerebroventricular (i.c.v.) injection of vehicle (0.6% saline) or 5-aza-2’deoxycytidine 
(10 mM) to premetamorphic (NF stage 50) X. laevis tadpoles for 4 days. I also treated these 
tadpoles with vehicle (0.0003% DMSO) or T3 (1.5 nM) by directly adding them to the aquarium 
water. I harvested tadpole brain four days after I had initiated T3 treatment. I isolated genomic 
DNA from the whole brain and conducted chop-qPCR assays targeting the klf9 and dnmt3a 
T3RE regions. Amplification of target genomic regions was normalized to that of genomic region 
that did not contain restriction sites. Bars represent the means ± SEM (n=4/treatment group), and 
letters above the means indicate statistically significant differences among treatments (means 
with the same letter are not significantly different) (dnmt3a T3RE : F(3,12) = 29.652, p < 0.001; 






Fig. 3.4. Methylation of CpG sites within Xenopus klf9 and dnmt3a T3RE regions reduces 
T3-dependent transactivity. I in vitro methylated or mock-treated CpG-less luciferase reporter 
plasmids (pCpGL; gift of Michael Rheli) into which I had subcloned genomic fragments that 
encompass the X. tropicalis klf9 and dnmt3a T3RE regions, and tested for transactivity in 
transient transfection assays using Neuro2a[TRβ1] cells. After transfection I treated cells with 
vehicle (0.1% DMSO) or T3 (30 nM) for 24 hrs before dual luciferase assay. Both genomic 
fragments supported T3-dependent transactivity, which was strongly reduced or abolished by 
CpG methylation. The genomic fragment of CpG-less CMV/EF1 promoter also supported T3-
dependent transactivity but CpG methylation of this fragment did not affect its transactivity. Bars 
represent the mean fold changes in firefly luciferase activity normalized to those of respective 
non-methylated plasmids in cells treated with vehicle (normalized to 1; n=3/treatment). Letters 
above the means indicate statistically significant differences among treatments (means with the 
same letter are not significantly different) (klf9 T3RE : F(3,8) = 281.749, p < 0.001; dnmt3a T3RE : 
F(3,8) = 21.630, p < 0.001; CMV/EF1: F(3,8) = 57.085, p < 0.001; ANOVA). I analyzed 
transfection efficiency by measuring abundance of plasmids in cell lysate using qPCR, which did 







Fig. 3.5. Methylation of CpG sites within the klf9 and dnmt3a T3RE regions does not affect 
TRβ-RXRα binding. I conducted a competitive EMSA using [32P]-labeled genomic fragments 
that encompass X. tropicalis klf9 (~180 bp) or dnmt3a T3REs (~320 bp) as probes, and 
corresponding radioinert genomic fragments that had been in vitro methylated with or without 
M.Sssi CpG methyltransferase. Before gel electrophoresis I incubated the probes with in vitro 
synthesized Xenopus TRβ plus RXRα, with or without the indicated radioinert genomic 
fragments (1-10 nM). The arrow indicates the location of supershifted bands due to TRβ-RXRα 
binding to the probe. Both genomic fragments displaced TRβ-RXRα binding to the probe in a 
concentration-dependent manner; CpG methylation of both genomic fragments did not change its 





GENOME-WIDE ANALYSIS OF CHANGES IN DNA METHYLATION AND GENE 
TRANSCRIPTION IN XENOPUS TADPOLE BRAIN DURING METAMORPHOSIS 
 
Abstract 
Methylation of cytosines in DNA (DNA methylation) is a key epigenetic modification 
that influences gene transcription. Recent studies in mammals and my thesis work in Xenopus 
showed a dramatic reorganization of DNA methylation in the developing brain. To investigate a 
role for DNA methylation in regulation of developmental gene expression programs, I conducted 
methylated DNA capture sequencing (MethylCap-seq) and RNA-sequencing (RNA-seq) in X. 
tropicalis tadpole brain at four stages of metamorphosis (NF stages 50, 56, 62 and 66). The 
MethylCap-seq analysis identified 141,700 loci in the neural cell genome that are enriched for 
methylated cytosines (methylation peaks), among which 855 peaks showed changes during 
metamorphosis. Consistent with my findings in Chapter 3 that the tadpole brain genome became 
demethylated during metamorphosis, differentially methylated regions (DMRs) identified 
between NF stage 66 (end of metamorphosis) and three earlier stages predominantly showed 
decrease in DNA methylation. Differentially methylated regions between mid-prometamorphosis 
and metamorphic climax (NF stages 56 and 62) predominantly showed increase in DNA 
methylation, coincident with upregulation of the de novo DNA methyltransferase 3a (dnmt3a) 
gene in tadpole brain. The RNA-seq analysis identified 5,280 unique genes that became 
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differentially expressed during metamorphosis in tadpole brain. Using clustering and gene 
ontology analyses, I identified thirteen patterns of gene expression dynamics and found that the 
cell cycle was the major pathway downregulated during metamorphosis. By combining the 
MethylCap-seq and RNA-seq data, I investigated the potential correlation between changes in 
DNA methylation and expression of genes that are found in 50 kb vicinity of DMRs. While the 
majority of genes did not show correlated changes in expression, my preliminary analysis found 
a weak, but significant inverse correlation between changes in DNA methylation and changes in 
gene expression. My findings suggest a role for DNA methylation in regulation of gene 





Methylation at carbon-5 position of cytosine in DNA (5-methylcytosine; 5-mC) is a 
critical epigenetic modification that controls gene transcription. In vertebrate genomes DNA 
methylation occurs in the context of cytosine-guanine (CpG) dinucleotides in most cells, 
although recent research has shown that the neural cell genome is enriched for methylated 
cytosines also in the cytosine-adenine (CpA) context (1-3). Changes in DNA methylation during 
embryogenesis play an important role in imprinting, X-chromosome inactivation and 
establishing tissue-specific gene expression programs {Hackett, 2013 #107}.  
Recent research has shown that global changes in DNA methylation also occur during 
postembryonic development. A recent genome-wide analysis of 5-mC conducted in mouse and 
human cerebral cortex showed a dramatic increase in CpA methylation during early postnatal 
period (2). In Chapter 3, I also found that the genome of Xenopus tadpole brain undergoes global 
changes in DNA methylation during metamorphosis. The abundance of 5-
hydroxymethylcytosine (5-hmC), which is an intermediate substrate of the active DNA 
demethylation pathway (4), similarly increases in postnatal mouse brain (2,5). Developmental 
changes in DNA methylation may play a crucial role in neural cell maturation and function. 
Lister and colleagues (2) found that increase in CpA methylation coincides with a period of 
synaptogenesis. They also found that decrease in the gene body methylation correlated with 
downregulation of neuron-specific genes in glial cells, suggesting a specific role for DNA 
methylation in cell differentiation and establishing neural cell type-specific transcriptome. 
To better understand DNA methylation changes in neural cell genome during 
postembryonic development, I conducted a high-throughput methylated DNA capture 
sequencing (MethylCap-seq; (6)) analysis on X. tropicalis preoptic area/hypothalamus (including 
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the pituitary) at four stages of metamorphosis: premetamorphosis (NF stage 50), mid-
prometamorphosis when cell proliferation peaks in tadpole brain (NF stage 56; (7)), 
metamorphic climax (NF stage 62) when plasma [T3] and [T4] reach their highest titers in tadpole 
brain (NF stage 62; (8)) and at the completion of metamorphosis (NF stage 66). To correlate 
changes in DNA methylation with changes in gene transcription, I also conducted RNA-
sequencing (RNA-seq) analysis on the same brain regions at the same four stages of 
metamorphosis. 
  
Materials and Methods 
Animal care and thyroid hormone (T3) treatment of Xenopus tadpoles 
X. tropicalis tadpoles were obtained by in-house breeding, reared in dechlorinated tap 
water (23 – 25 °C), maintained at 12L:12D photoperiod and fed ad libitum with pulverized frog 
brittle powder (NASCO, Fort Atkinson, WI). The normal table of Nieuwkoop and Faber (NF) 
(1994) was used to assign developmental stages. Tadpoles were killed by rapid decapitation, 
brain tissues were extracted, and snap frozen in liquid nitrogen and stored at –80 °C until RNA 
or DNA extraction. All procedures involving animals were conducted in accordance with the 
guidelines of the University Committee on the Care and Use of Animals of the University of 
Michigan. 
 
Spike-in control for the Methylated DNA Capture (MethylCap) assay 
In Chapter 3, I found that the genome of Xenopus tadpole brain became demethylated 
during metamorphosis. Since this might lead to differences in efficiency of methylated DNA 
capture among samples during the MethylCap assay, I used spike-in control DNA to monitor the 
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capture efficiency.  
I synthesized the spike-in control as described in Taiwo et al. (2012) (9) with 
modifications. I first PCR amplified four different DNA fragments from the lambda phage 
genome that differed in CpG density (two with low-CpG and two with high CpG density; see 
Supplemental Table 4.1 for primer sequences). I methylated two of these DNA fragments (one 
low-CpG and one high-CpG density) in vitro by incubating them with 10 units of M.SssI CpG 
methyltransferase (New England Biolabs (NEB), Ipsiwich, MA) and S-adenosylmethionine 
(SAM; 640 µM) for eight hours; four hours into reaction I replenished SAM. I purified the DNA 
fragments using phenol/chloroform/isoamyl alcohol precipitation (Invitrogen Life Technologies, 
Carlsbad, CA) and resuspended in buffer EB (Qiagen, Valencia, CA). I verified successful in 
vitro methylation by digesting the DNA fragments with Hinp1I restriction enzyme that is 
sensitive to CpG methylation (NEB; 10 units per reaction) (data not shown). I combined the four 
DNA fragments (two methylated and two non-methylated) into one to make a cocktail (0.2 pM). 
I added this cocktail to Buffer B of the MethylCap kit (Diagenode, Denville, NJ) in 1:30 dilution 
before the capture reaction. 
 Real-time qPCR assay showed that the MethylCap assay efficiently captured methylated 
spike-in DNA in a CpG density-dependent manner and that the capture efficiency did not vary 
significantly among samples (Supplemental Fig. 4.1). A recent study showed that the methyl 
CpG-binding domain of human MeCP2 binds to methylated CpAs at a similar affinity as 
methylated CpGs (10). When this study was published I had already completed the experiment, 





Genomic DNA extraction, the MethylCap assay, and MethylCap-seq 
 I microdissected the preoptic area/hypothalamus (including the pituitary) from X. tropicalis 
tadpoles at NF stages 50, 54, 56, 58, 62 and 66, and extracted genomic DNA using the DNeasy 
Blood and Tissue kit (Qiagen) (n=4/stage). For each biological replicate I pooled tissues from 
fifteen animals for NF stage 50, eight for stage 54, five for stage 56, five for stage 58, six for 
stage 62 and six for stage 66. 
 I sonicated 5 µg of genomic DNA to an average size of 400 bp using the Covaris S2 
sonicator (Covaris, Woburn, MA), then used 1 µg of sonicated DNA to conduct the MethylCap 
assay using the MethylCap kit (Diagenode) following the manufacturer’s protocol with the 
following modifications. Before the capture reaction, I added the spike-in control cocktail 
(described above) to Buffer B in 1:30 dilution to monitor the efficiency of methylated DNA 
capture. I collected flow-through and fractions that were serially eluted with low-, mid- and high-
salt elution buffer. Input and high-salt fractions were further purified with the QIAquick PCR 
Purification kit (Qiagen), while other fractions were left unpurified and stored at -80 °C. 
Although the capture efficiency of the spike-in control did not vary significantly among samples 
as analyzed by real-time qPCR (Supplemental Fig. 4.1), I adjusted the final volume of eluates 
based on the qPCR result for MethylCap-seq, so that all samples contained the same 
concentration of the spike-in control. For sequencing I selected three biological replicates of 
high-salt fractions for each of the following four stages: NF stages 50 (premetamorphosis), 56 
(mid-prometamorphosis), 62 (metamorphic climax) and 66 (end of metamorphosis); I also 
selected one input sample each from NF stage 50, 56 and 62 (one sample each). These 15 




 The sequencing library was constructed on the Apollo instrument (an automated system) 
using IntegenX reagents (now Wafergen, Fremont, CA). DNA fragments were end repaired, 
adenylated, ligated with adapters that contain hexanucleotide barcodes, PCR amplified and 
pooled. One pool of libraries contained twelve libraries for high-salt fractions, while the other 
pool of libraries contained three libraries for input samples. Final libraries were assessed for their 
quality using the TapeStation (Agilent Technologies, Santa Clara, CA), quantified by qPCR 
using a commercial kit (Kapa Biosystems, Wilmington MA), and sequenced to produce single-
end 50 bp reads on Illumina HiSeq 2000 platform with High Output mode using version 3 
reagents. The libraries for high-salt fractions were sequenced twice, once using two flow cells 
and a second time using six additional flow cells to increase the number of reads. The libraries 
for input samples were sequenced once using two flow cells. 
 
MethylCap-seq data processing and analysis 
 I filtered raw sequencing reads to remove duplicate reads using a custom script, and then 
assessed their quality using FastQC software (version 0.10.1) 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). I mapped the reads to the X. 
tropicalis genome (version 4.1) (11) using Bowtie software (version 1.0.0) (12). Prior to final 
mapping I conducted preliminary analyses to determine a parameter to produce the maximum 
number of aligned reads by adjusting the seed-length (“-l”), number of nucleotides to trim from 
the 5’ and/or 3’ ends of the reads (“-5” and “-3”, respectively) and the number of sequence 
mismatches allowed (“-n”). Based on this analysis (data not shown), I uniquely mapped the reads 
using 50 bp as the seed-length with 1 bp mismatch allowed (“–l 50 –m 1 –n 1”). The number of 
aligned reads is provided in Supplemental Table 4.2. The Bowtie output file was converted to the 
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BED format for subsequent analyses.  
 I identified genomic regions that are enriched for methylated DNA (‘methylation peaks’) 
using PePr software (13) with the default parameters plus the “--remove artefacts” option 
included. I identified differentially methylated regions (DMRs) by additionally including the “--
diff” option. The “--window_size” parameter was set to “400 (bp)” because this was the average 
fragment size of sonicated DNA used for the MethylCap assay; my preliminary analysis also 
showed that this window size yielded an optimal number of peaks among different window sizes 
tested (data not shown). For each of these analyses I ran the analysis twice by setting the “--
peak_type” option to be “sharp” for the first run and “broad” for the second run. I combined 
these two data sets together using “mergeBed” function of Bedtools software (version 2.20.1) 
(14) for subsequent analyses.  
 I used “intersectBed” function of Bedtools software (version 2.20.1) (14) to identify the 
overlap between methylation peaks (or DMRs) and the following annotated genomic regions: 
upstream regions (0 to 10 kb 5’ from the TSS in 1 kb increments), downstream regions (0 to 10 
kb 3’ from the TSS in 1 kb increments) and intragenic region (gene body) of the annotated genes. 
I used the MNHN gene model (described below) to identify these regions. 
 
RNA extraction and RNA-sequencing (RNA-seq) library preparation 
 I microdissected the preoptic area/hypothalamus (which included the pituitary) from X. 
tropicalis tadpoles at NF stages 50, 54, 56, 58, 62 and 66. I extracted total RNA from tissue 
using TRIZOL reagent (Invitrogen) and further purified it with the RNeasy Mini kit (Qiagen). 
For RNA-seq I selected three of five biological replicates for the same four stages of 
metamorphosis as MethylCap-seq (NF stages 50, 56, 62 and 66), and submitted them to the 
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University of Michigan DNA sequencing core for sequencing library preparation. 
 All samples had RIN (RNA Integrity Numbers) of 8 or greater as analyzed by the 
TapeStation (Agilent). Each library was prepared from 130 ng of RNA using the Illumina 
TruSeq mRNA Sample Prep v2 kit (Illumina Inc., San Diego, CA), where total RNA was poly-A 
selected, fragmented and reverse transcribed with random primers. The 3’ ends of the cDNA 
library were adenylated, ligated with adapters that contain hexanucleotide barcodes, and PCR-
amplified to construct the final library. The final libraries were assessed for their quality using 
the TapeStation (Agilent) and quantified by qPCR using a commercial kit (Kapa Biosystems). 
All libraries were pooled and sequenced to produce single-end 50 bp reads in two flow cells on 
the Illumina HiSeq 2000 platform with High Output mode using version 3 reagents. 
  
RNA-seq data processing and analysis 
 I conducted quality control and post-processing of raw sequencing reads, and the same 
preliminary analysis for Bowtie mapping as described above for MethylCap-seq. Based on the 
preliminary analysis (data not shown), I used a parameter to first trim 21 bp from the 5’end of 
the reads and then uniquely map them to the genome using 30 bp as the seed-length with 1 bp 
mismatch allowed (“-5 21 –l 30 –m 1 –n 1”). The number of aligned reads is provided in 
Supplemental Table 4.2. The Bowtie output file was converted to the BED format for subsequent 
analyses. 
 I used the “intersectBed” function of Bedtools software (version 2.20.1) (14) to count the 
number of reads that overlapped with each of 22,820 custom annotated X. tropicalis genes (‘gene 
counting’). This custom annotation (the MNHN gene model) was built by Laurent Sachs and 
colleagues based on their unpublished high-throughput RNA pair-end tagging (RNA-PET) 
! !
! 87!
sequencing analysis to identify the 5’ and 3’ ends of transcripts that were expressed in various X. 
tropicalis tissues including the brain. After gene counting I used DESeq software (version 
1.12.0) (15) to identify differentially expressed genes at a false discovery rate of 5% with the 
following parameters: method=”pooled”; sharing-mode=”maximum”; fit-type=”parametric”.  
 The RNA-seq analysis identified 5,220 unique genes that became differentially expressed 
in tadpole brain during metamorphosis (see Results). Using a list of genes that became 
differentially expressed between NF stage 50 (premetamorphosis) and any of the three later 
stages (1,979 genes), I conducted fuzzy c-mean clustering (which is similar to k-means clustering 
but less sensitive to noise) (16) to identify patterns of gene expression dynamics during 
metamorphosis. I first sorted the 1,979 genes into 81 clusters, and then grouped similar clusters 
into 13 general patterns as described in the Results section. ⁠I conducted gene ontology and 
KEGG pathway analyses of differentially expressed genes using g:Profiler software (17) with the 
default parameters. 
 
Reverse transcriptase real-time quantitative PCR (RTqPCR) 
 To validate RNA-seq I conducted RTqPCR as described in Chapter 3 for 14 genes chosen 
based on their type of regulation (up-, down- or non-regulated) and transcript abundance (low, 
medium and high). For this analysis I included three RNA samples used for sequencing and two 
additional samples not used for sequencing. The list of 14 genes and primer sequences are 





Identification of genomic regions that undergo changes in DNA methylation during 
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Xenopus metamorphosis using MethylCap-seq  
The Methylated DNA capture (MethylCap) assay enriches (‘captures’) methylated 
cytosines using the recombinant methyl-CpG-binding domain (MBD) of human MeCP2 protein 
that has affinity for both CpG and CpA methylation (10). I sequenced fraction that was eluted 
with high-salt elution buffer and input samples and generated 95.2 million and 72.6 million reads 
respectively per sample (Supplemental Table 4.2). I aligned the reads to the X. tropicalis genome 
using a parameter to remove sequences that appear more than once in the genome (i.e. unique 
mapping), and obtained 15.2 million mapped reads for high-salt samples and 30.9 million 
mapped reads for input samples (Supplemental Table. 4.2). This mapping parameter removed 
more reads from high-salt samples (31.8%) than input samples (21.0%), suggesting that high-salt 
samples contained a higher amount of repeat sequences in the genome (Supplemental Table. 4.2).  
Using PePr software (13) I identified 141,700 unique genomic regions that are enriched 
for methylated DNA (‘methylation peaks’). The width of methylation peaks ranged from 400 bp 
to 15.8 kb with the average of ~1 kb. About 57% of peaks overlapped with intra-genic regions, 
while the rest of the peaks fell within inter-genic regions. Roughly 29% of total peaks overlapped 
within 10 kb upstream and downstream of transcription start sites. Differential peak analysis 
using PePr software (13) identified 855 methylation peaks that showed changes during 
metamorphosis (coordinates of these differentially methylated regions (DMRs) are provided in 
Supplemental Table 4.4). The extent of overlap in intra-genic regions was similar among DMRs 
(62%). Roughly 30% of DMRs overlapped within 10 kb upstream and downstream of 
transcription start sites. 
Pair-wise differential peak analysis identified 25 methylation peaks that showed increase 
and 24 methylation peaks that showed decrease between premetamorphosis (NF stage 50) and 
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mid-prometamorphosis (NF stages 56) (Fig. 4.1). Larger numbers of methylation peaks exhibited 
changes between premetamorphosis and metamorphic climax (NF stage 62; 144 increase and 
149 decrease), and between premetamorphosis and the end of metamorphosis (NF stage 66; 41 
increase and 195 decrease) (Fig. 4.1), indicating that more changes in DNA methylation occurred 
during later stages of metamorphosis. Similar pair-wise analyses between the end of 
metamorphosis (NF stage 66) and three earlier stages showed that the majority of DMRs (76-
91%) showed decrease in DNA methylation (Fig. 4.1), consistent with my findings in Chapter 3 
that the tadpole brain genome became demethylated during metamorphosis. In Chapter 2, I found 
that mRNA for the de novo DNA methyltransferase 3a (dnmt3a) gene increased in tadpole brain 
between mid-prometamorphosis and metamorphic climax (NF stages 56 and 62). Consistent with 
this there were more peaks that showed increase in DNA methylation (82) than those that 
showed decrease (29) between these two stages (Fig. 4.1). 
 
Identification of differentially expressed genes in Xenopus tadpole brain during 
metamorphosis using RNA-sequencing (RNA-seq) 
To identify genes that might show correlated changes in expression, I conducted RNA-
sequencing (RNA-seq) analysis on the preoptic area/hypothalamus (including the pituitary) of X. 
tropicalis tadpoles at the same four stages of metamorphosis as for MethylCap-seq analysis. I 
generated 27.4 million reads and uniquely mapped 10.8 million reads to the X. tropicalis genome 
per sample (Supplemental Table 4.1). To validate RNA-seq results I conducted RTqPCR for 14 
genes (6 up-, 6 down- and 2 non-regulated) chosen based on their transcript abundance (low, 
medium and high). All genes tested by RTqPCR showed similar developmental expression 
dynamics as they did by RNA-seq (Supplemental Fig. 4.2; gene annotation and primer sequences 
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are provided in Supplemental Table 4.3). 
Using DESeq software (15) I found that 5,220 of 22,820 annotated genes showed 
changes in expression in tadpole brain during metamorphosis. Using the list of differentially 
expressed genes between premetamorphosis (NF stage 50) and any one of the three later stages 
(NF stages 56, 62, and 66) (1,979 genes), I conducted fuzzy c-means clustering analysis and 
identified thirteen patterns of gene expression dynamics (Fig. 4.2 and Supplemental Fig. 4.3). 
While there was one pattern that was unique to a group of upregulated genes (pattern 1) in which 
they showed highest expression at mid-prometamorphosis (NF stage 56) and declined towards 
the end of metamorphosis, the remaining twelve patterns could be divided into six pairs of 
upregulated and downregulated genes based on their roughly inverse expression patterns (Fig. 
4.2). The first pair exhibited a simple pattern as they increased (pattern 2) or decreased (pattern 
3) continuously throughout metamorphosis, while another pair exhibited a more complex 
dynamics that involved a transient increase or decrease (patterns 4 and 5). The third and fourth 
pairs exhibited peak expression at metamorphic climax (NF stage 62) and either reached a 
plateau (pattern 6 and pattern 7), or decreased (pattern 8) or increased (pattern 9) between 
metamorphic climax and the end of metamorphosis (NF stage 62 and 66). The fifth pair 
exhibited a sharp increase (pattern 10) or decrease (pattern 11) between premetamorphosis and 
mid-prometamorphosis (NF stages 50 and 56) but did not show further changes for the remainder 
of metamorphosis. The last pair had unique characteristics in that they did not change until after 
mid-prometamorphosis (NF stage 56; patterns 12 and 13) (see Supplemental Table 4.5 for the list 
of genes in each pattern). 
I also identified differentially expressed genes among the four stages of metamorphosis 
by pair-wise comparisons (Fig. 4.3) (the complete list of differentially expressed genes is 
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provided in Supplemental Table 4.6), and then investigated enrichment of pathways using gene 
ontology (GO) and KEGG/Reactome pathway analyses. Between premetamorphosis and mid-
prometamorphosis (NF stages 50 and 56), I found 311 upregulated and 627 downregulated genes 
(Fig. 4.3). While there was no enrichment of pathways among upregulated genes, I found 
enrichment of pathways involved in cell cycle and p53 signaling (apoptosis) among 
downregulated genes (Supplemental Table 4.7).  
The RNA-seq analysis identified 655 upregulated and 732 downregulated between mid-
prometamorphosis and metamorphic climax (NF stages 56 and 62), coinciding with a dramatic 
increase in plasma [T3] (Fig. 1.1). The cell cycle pathway was again enriched among 
downregulated genes, consistent with previous findings from my laboratory that the rate of cell 
proliferation in tadpole brain peaks at mid-prometamorphosis and declines towards metamorphic 
climax (7). The metabolic and biosynthetic pathways were other major pathways enriched 
among downregulated genes (Supplemental Table 4.7). Although there were similar numbers of 
upregulated and downregulated genes, only a few pathways were enriched among upregulated 
genes (Supplemental Table 4.7), one of which was hormone-mediated signaling pathway that 
included genes that code for thyroid hormone (TR) β and its heterodimerization partner Retinoid 
X receptor (RXR) α.  
A small set of genes (137) showed changes  in expression between metamorphic climax 
and the completion of metamorphosis (NF stage 62 and 66) (Fig. 4.3). Again, I found no 
enrichment of pathways among 69 upregultad genes, while I found enrichment of pathways 
involved in metabolism of lipids and lipoproteins among 68 downregultaed genes (Supplemental 




Correlation between changes in DNA methylation and gene expression changes in during 
metamorphosis 
I investigated possible correlations between developmental changes in DNA methylation 
and expression of genes that are in the 50 kb vicinity of DMRs. While I did not find such 
correlations for changes that occur during short developmental time intervals (i.e. between NF 
stages 50 and 56, NF stages 56 and 62, and NF stages 62 and 66), I found some correlations for 
changes that occur during longer developmental time intervals (NF stages 50 and 62, NF stages 
56 and 66 and NF stages 50 and 66) (the complete list of genes that showed correlated changes is 
provided in Supplemental Table 4.8).  
The RNA-seq analysis identified 311 upregulated and 627 downregulated genes (among 
22,820 annotated genes) between premetamorphosis and metamorphic climax (NF stages 50 and 
62) (Fig. 4.3). This predicted that I would find 21 upregulated and 24 downregulated genes by 
random correlation among 268 genes that are in 50 kb vicinity of methylation peaks that showed 
decrease (i.e. demethylated) between these two stages. My analysis identified 38 upregulated and 
28 downregulated genes, which statistically exceeded the number of genes predicted by random 
correlation (Fig. 4.4). I found 229 genes in the 50 kb vicinity of peaks that showed increase in 
DNA methylation (i.e. methylated) between the two stages; however, I did not find statistically 
significant correlation for these genes (data not shown). 
Between mid-prometamorphosis and the end of metamorphosis (NF stages 56 and 66) I 
identified 833 upregulated and 854 downregulated genes (Fig. 4.3). Among 193 genes in 50 kb 
vicinity of methylation peaks that showed decrease, a random correlation predicted to find 7 
upregulated and downregulated genes each; my analysis found 17 upregulated genes (2.4-fold 
enrichment) and 3 downregulated genes (2.3-fold underrepresentation) (Fig. 4.4). There were 44 
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genes in 50 kb vicinity of methylation peaks that showed increase; I found 4 upregulated and 
downregulated genes each while random correlation predicted to find 2 of each (Fig. 4.4).  
Between the beginning and end of metamorphosis (NF stages 50 and 66) RNA-seq 
analysis identified 1,926 upregulated and 2,172 downregulated genes. A random correlation 
predicated to find 37 upregulated genes and 42 downregulated genes among 440 genes that are 
found in 50 kb vicinity of methylation peaks that showed decrease between these two stages. 
While I found roughly twice as many number of upregulated genes predicted by random 
correlation (75 genes), I found the same number of downregulated genes predicted by chance (i.e. 
no enrichment; 42 genes) (Fig. 4.4). There were 56 genes in 50 kb vicinity of methylation peaks 
that showed increase. I found 7 upregulated and 13 downregulated genes, while random 
correlation predicted to find 5 of each (Fig. 4.4). 
 
Discussion 
The neural cell genome undergoes dramatic changes in DNA methylation during 
postembryonic development. To identify genomic regions that go through deveopmntal changes 
in DNA methylation, and also to investigate the role of such changes in gene transcription in the 
brain, I conducted MethylCap-seq and RNA-seq on X. tropicalis tadpole brain at different stages 
of metamorphosis. The MethylCap-seq analysis identified distinct loci in the genome that 
showed increase and decrease in DNA methylation, while RNA-seq analysis identified genes 
that became differentially expressed in tadpole brain during metamorphosis. I also found a weak, 
but significant inverse correlation between changes in DNA methylation and changes in 
expression of genes that are found in 50 kb vicinity of differentially methylated regions (DMRs). 
Although more rigorous analysis of both MethylCap-seq and RNA-seq is required, my findings 
! !
! 94!
suggest that DNA methylation may play a role in transcriptional regulation of genes in the 
developing brain.  
 
 DNA methylation changes in Xenopus tadpole brain during metamorphosis  
Using MethylCap-seq I identified 141,700 distinct regions that are enriched for 
methylated DNA (‘methylation peaks’) in the genome of X. tropicalis tadpole brain. However, 
the majority of these methylation peaks did not show changes during metamorphosis, and I only 
found 855 methylation peaks that became differentially methylated. In Chapter 3, I found ~50% 
reduction in methylated cytosines in the developing tadpole brain using 5-mC ELISA; in 
comparison, changes detected by MethylCap-seq analysis were much smaller (0.6% of all 
methylation peaks).  
There are several factors that might have contributed to the difference in the magnitude of 
changes detected by ELISA and MethylCap-seq. First, while 5-mC ELISA detects methylated 
cytosines in any sequence context, the MethylCap assay can detect only those in CpG and CpA 
contexts (10). Second, although I used low-, mid- and high-salt elution buffers to serially elute 
captured DNA during the MethylCap assay, I only analyzed the high-salt fraction for sequencing 
analysis, which restricted my analysis to a small subpopulation of all methylated cytosines 
present in the genome. Third, I also conducted the assays using two different frog species: while 
I used X. laevis tadpoles for 5-mC ELISA in Chapter 3, I used X. tropicalis tadpoles for 
MethylCap-seq analysis. A previous study by Head and colleagues (18) has shown that the 
genome of X. tropicalis frog brain is relatively less methylated than that of X. leavis (76% and 
91% of MspI/HpaII restriction sites were methylated as analyzed by Luminometric Methylation 
Assay (LUMA) (19)). Because of this species difference, changes in DNA methylation may be 
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less dynamic in X. tropicalis than in X. laevis. In support of this, I found larger DNA 
demethylation at regions that contain klf9 and dnmt3a T3REs in X. laevis than in X. tropicalis 
(Chapter 3). Lastly, mapping of MethylCap-seq reads showed that the high-salt fraction had a 
higher content of sequences that are repeated in the genome, as more reads were removed from 
high-salt samples than input samples during alignment (31.8% versus 21.0% of reads) 
(Supplemental Table 4.1), which may be consistent with a role for DNA methylation in silencing 
of repetitive elements (20). Taken together, changes in DNA methylation identified by 
MethylCap-seq analysis may not be representative of changes that occur at the whole genome 
scale, particularly in regions that have a lower density of methylated cytosines. Sequencing of 
the low- and mid-salt fractions is required for more comprehensive analysis of changes in DNA 
methylation that occur in the tadpole brain. 
  
Gene expression changes in Xenopus tadpole brain during metamorphosis  
To better understand the molecular basis of tissue morphogenesis during postembryonic 
development, and to investigate a potential correlation between gene expression and DNA 
methylation changes, I conducted RNA-seq on X. tropicalis tadpole brain at the same stages of 
metamorphosis as in MethylCap-seq. My study represents the first transcriptome analysis of 
Xenopus tadpole brain (or any tadpole tissue) following their development; prior transcriptome 
analyses using microarrays have been conducted only on premetamorphic tadpole after T3 
treatment or inhibition of T3 synthesis (reviewed in Kulkarni and Buchholz, 2013 (21)). My 
RNA-seq analysis identified 5,220 unique genes that became differentially expressed, thirteen 
distinct patterns of gene expression dynamics, and enriched pathways among differentially 
expressed genes during metamorphosis.  
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Genes that are involved in cell cycle control were strongly downregulated during 
metamorphosis. Gene ontology analysis identified the pathway twice during the transition from 
premetamorphosis to mid-prometamorphosis (NF stages 50 and 56), and then again during the 
transition from mid-prometamorphosis to metamorphic climax (NF stages 56 and 62). The 
repressed genes included the cyclins (ccna2, ccnb2, ccnb3, ccne1, ccne2), cyclin-dependent 
kinases (cdk1, cdk4), and subunits of protein complexes that are involved in DNA synthesis and 
replication, such as MCM replication licensing factor complex and ORC origin recognition 
complex. All of these genes are known targets of E2F transcription factors, the master regulators 
of the transition between G1 and S phase of the cell cycle (22); the genes that code for E2F 
protein (e2f1, e2f3, e2f5) also exhibited decreases by the time tadpole reaches metamorphic 
climax. Robust downregulation of cell cycle genes may explain the decline of cell proliferation 
in tadpole brain that occurs during metamorphosis (7), although this needs further investigation.   
On the contrary I found only a small number of enriched pathways among upregulated 
genes; this was not due to a low number of genes included in the analysis (311 genes for 
comparison between NF stages 50 and 56; 655 genes for comparison between NF stages 56 and 
62; and 69 genes between stages 62 and 66). This may imply that there is a greater diversity of 
pathways regulated by genes that are induced during metamorphosis than those that are repressed. 
The annotation of the X. tropicalis genome is still far from complete (23); therefore, it is also 
possible that functions are not assigned for a large number of activated genes.  
 




I investigated whether genes that are found in the 50 kb vicinity of DMRs would exhibit 
correlated changes in expression, and my analysis supported a weak, but statistically significant 
inverse correlation between changes in DNA methylation and gene expression changes (Fig. 4.4). 
For example, I found twice as many upregulated genes (75 genes found; 37 genes predicted by 
chance) that are close to regions that became demethylated between NF stage 50 and 66; whereas, 
I did not find such enrichment for downregulated genes within the same regions (42 genes found; 
42 genes predicted by chance) (Fig. 4.4). It is noteworthy that I found a correlation between 
DNA demethylation and activation of genes that are important for neural cell maturation and 
function. This includes genes that code for subunits of neurotransmitter receptors (grin1, gabra2), 
the enzyme that synthesize GABA, the major inhibitory neurotransmitters in the brain (gad2), 
subunits of potassium and calcium voltage-gated channels that regulate neural cell excitability 
(kcng2, cacna1g) and receptors for brain-derived and glial-derived tropic factors (BDNF and 
GDNF) (ntrk2, gfra1). 
Further analysis is required to identify the precise location of DMRs with respect to the 
genes that showed correlated changes in expression, and to investigate if these DMRs overlap 
with gene regulatory regions such as promoters and enhancers. In mouse brain DMRs that 
exhibit changes in CpG methylation were more likely to overlap with enhancers that are marked 
by mono methylation of lysine 4 of histone 3 (H3K4me1) and acetylation of lysine 27 of histone 
3 (H3K27ac) (2). No genome-wide analyses of these histone marks have been conducted in 
Xenopus tadpole brain. Conducting such experiments to identify enhancers in tadpole brain may 
be informative for understanding the functional relevance of DNA methylation changes 
identified by MethylCap-seq. 
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While my analysis supported a general correlation between DNA demethylation and 
activation of genes nearby, the majority (76-91%) of genes did not show such correlated changes 
in expression, which may be due to limitations of my approach. First, I included all DMRs for 
analysis regardless of whether they overlap with gene regulatory regions, which may have 
diluted the overall effect in the analysis. Previous studies supported correlated changes in gene 
expression and methylation changes at gene bodies and enhancer regions (24). Therefore, 
investigating the correlation for a subset of DMRs that overlap with defined genomic regions 
may support a stronger correlation. Another limitation of my approach was that I investigated the 
correlation based only on physical distance (i.e. within 50 kb) between genes and DMRs. Gene 
regulatory regions such as enhancers could be located more than 50 kb away from regulated 
genes. For example, my lab recently identified an enhancer located 72 kb upstream of human 
Krupple-like factor 9 (KLF9) gene that interacts with its promoter through long-range 
chromosomal interaction (25). Investigating such interaction between DMRs and genes using a 
technique such as 5C (26) will establish a more direct functional linkage between changes in 
DNA methylation and correlated changes in gene expression.  
 In conclusion, I identified genomic regions that showed changes in DNA methylation and 
genes that became differentially expressed in Xenopus tadpole brain during metamorphosis. My 
preliminary analysis found an inverse correlation between changes in DNA methylation and 
expression of genes that are close to DMRs. To my knowledge, this is the first study to 
investigate DNA methylation changes in any Xenopus tadpole tissues during metamorphosis, and 
is also the first to conduct RNA-seq in tadpole brain. The present study laid an important 
groundwork for investigating roles of DNA methylation and gene expression changes in Xenopus 
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Fig. 4.1. Identification of genomic regions that exhibit changes in DNA methylation in X. 
tropicalis tadpole brain during metamorphosis using MethylCap-seq. I conducted 
MethylCap-seq analysis on genomic DNA isolated from X. tropicalis tadpole brain at four 
different developmental stages of metamorphosis. Using peak-calling software PePr I identified 
genomic regions that are enriched for methylated DNA across the genome (‘methylation peaks’). 
I then conducted differential peak analysis to identify methylation peaks that exhibit 
developmental changes during metamorphosis (‘differentially methylated regions – DMRs’). The 
results of this analysis are summarized as pie charts. The numbers in the lighter area of pie charts 
indicate the number of DMRs that are more methylated in Stage A (i.e. demethylated in Stage B), 
and the numbers in the darker area of pie charts indicate the number of DMRs that are more 






Fig. 4.2. Differentially expressed genes in X. tropicalis tadpole brain exhibit distinct 
patterns of expression dynamics during metamorphosis. Using RNA-seq analysis I identified 
5,220 unique genes that exhibited changes in expression in X. tropicalis tadpole brain during 
metamorphosis. Using this list of differentially expressed genes, I conducted c-means clustering 
analysis to identify groups of genes that exhibited similar developmental dynamics of expression 
during metamorphosis. I first grouped these genes into 81 different clusters (see Supplemental 
Fig. 3 for all patterns), and then further grouped those clusters into 13 general patterns. Presented 







Fig. 4.3. The transcriptome of X. tropicalis tadpole brain exhibits dynamic changes during 
metamorphosis.. I conducted RNA-seq analysis on RNA isolated from X. tropicalis tadpole 
brain at the same four different developmental stages of metamorphosis as in MethylCap-seq. 
Using DESeq software I identified genes that exhibited changes in expression during 
metamorphosis (‘differentially expressed genes’). Shown are pie charts that summarize the 
number of differentially expressed genes. The numbers in red area of pie charts indicate the 
number of upregulated genes in Stage B, while the numbers in blue area of pie charts indicate the 





Fig. 4.4. Changes in DNA methylation correlate with expression of genes that are found 
within 50 kb. I investigated correlation between developmental changes in DNA methylation at 
differentially methylated regions (DMRs) and expression of genes that are in the neighbor of 
DMRs. To investigate this I first listed all genes that I found within the 50 kb flanking regions of 
DMRs, and then categorized those genes as upregulated, downregulated, or no changes in 
expression. I found statistically significant enrichment in the number of differentially expressed 
genes within the 50 kb flanking regions over the number of genes predicted by random 
association (χ2, p < 0.05). Bars represent log2-transformed fold enrichment in the number of 





CONCLUSIONS AND FUTURE DIRECTIONS 
 
Postembryonic neurological development is critically dependent on thyroid hormone (T3). 
The actions of T3 are mediated by ligand-modulated T3 receptors (TRs) that control target gene 
transcription through recruitment of histone-modifying enzymes. Compared to this known role of 
T3 in modulating posttranslational modification of histones, virtually nothing is known about the 
linkage between T3 signaling and DNA methylation, another critical epigenetic modification that 
controls gene transcription. It was previously thought that the genome-wide pattern of DNA 
methylation (methylome) is fixed throughout the life of an organism once it is established during 
embryogenesis. However, mounting evidence suggest that dynamic changes in the methylome 
continue beyond embryogenesis and particularly play crucial roles for neural cell development 
and function. 
In this thesis I described studies in which I investigated T3-dependent modulation of 
DNA methylation in the developing brain. My discoveries support that in addition to 
posttranslational modification of histones, T3 modulates the neural cell methylome through 
activation of genes that code for enzymes that methylate and demethylate the genome. 
 
Developmental and T3-dependent regulation of genes that code for enzymes that modulate 
DNA methylation and demethylation 
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 I investigated developmental and T3-dependent regulation of the gene that code for the de 
novo DNA methyltransferase 3a (dnmt3a), the key enzyme that catalyzes DNA methylation (1) 
in Xenopus tadpole brain (Chapter 2). Using real-time RT-qPCR I found that dnmt3a mRNA 
increased in tadpole brain during metamorphosis, coincident with increases in plasma [T3] and 
[T4] (2) (Fig. 5.1); treating premetamorphic tadpoles with exogenous T3 also induced dnmt3a 
mRNA. I further conducted molecular characterization of T3 response elements (T3RE) 
associated with the dnmt3a gene. By analyzing data from a ChIA-PET experiment conducted on 
tadpole tail fin chromatin with TR as the target protein (L. Sachs and N. Buisine, unpublished 
data), I identified three putative TR binding sites associated with the gene. Using this 
information I conducted targeted ChIP assays for TRs on brain chromatin and found that the 
receptors associated with 7.4 kb upstream and 4.7 kb downstream of the predicted translation 
start site of the frog dnmt3a gene. Within each locus I identified direct repeat plus a four 
nucleotide spacer (DR+4) T3REs using bioinformatics and comparative genomics approaches. I 
conducted EMSA, transient transfection-reporter assays and site-directed mutagenesis to show 
that they are functional T3REs that support T3-dependent transactivity, which may explain 
developmental and T3-dependent regulation of the frog dnmt3a gene.  
Given the findings in frog, evolutionarily conserved roles for T3 in vertebrate 
neurological development (3), and previous work showing a positive correlation between plasma 
thyroid hormone level and expression of Dnmt3a in the early postnatal mouse brain (4-7), I 
investigated whether the orthologous mouse Dnmt3a gene was similarly regulated by T3. I found 
that T3 rapidly induced Dnmt3a mRNA both in the neonatal brain and in Neuro2a[TRβ1] cells 
(Neuro2a neuroblastoma cell line that is engineered to express TRβ1 (8)); this induction was 
resistant to ongoing protein synthesis inhibition in Neuro2a[TRβ1] cells, further supporting that 
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Dnmt3a is directly regulated by T3. Using the same approaches as I used for characterizing the 
frog dnmt3a T3REs, I identified two functional T3REs at 30.1 and 49.0 kb downstream from the 
transcription start site of the mouse Dnmt3a gene. These findings strongly suggest that T3 
modulates DNA methylation in the developing brain through direct activation of the Dnmt3a 
gene.  
Future studies should investigate roles for DNMT3a in mediating T3 actions on the 
developing brain. Cell proliferation in the ventricular and subventricular zones (VZ/SVZ; 
neurogenic regions) of the tadpole brain exhibits a T3-dependent increase at the onset of 
metamorphosis (NF stage 50), peaks at mid-prometamorphosis (NF stage 56), then declines 
through late prometamorphosis and climax (9) (Fig. 5.1); this decline of cell proliferation 
inversely correlates with an increase in dnmt3a mRNA (Fig. 5.1). In situ hybridization 
histochemistry showed that in tadpole brain dnmt3a mRNA is widely expressed in cells that have 
migrated out of the VZ/SVZ, but not in neural stem cells that reside within the neurogenic 
regions (Chapter 2). Thyroid hormone is known to induce cell cycle exit and differentiation of 
neuronal progenitors (Neuro2a[TRβ1] cells) (8,10). Conversely, hypothyroidism prolongs cell 
proliferation in the postnatal mouse brain (4). These findings together suggest that DNMT3a may 
play a role in mediating T3 actions on cell differentiation, and I hypothesize that DNMT3a 
maintains cell cycle exit in differentiating neural cells through repression of cell cycle genes, 
such as Cyclin D1. Deletion of Dnmt3a gene in mouse causes dysregulation of cell cycle genes 
in neural stem cells derived from the SVZ (11). Thyroid hormone treatment of Neuro2a[TRβ1] 
cells reduces Cyclin D1 mRNA (10). DNA methylation of the Cyclin D1 promoter inversely 
correlates with Cyclin D1 gene expression (12), which may be catalyzed by DNMT3a (13,14). 
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Future studies should investigate whether T3 influences DNA methylation of cell cycle genes in 
the developing brain. 
I also investigated developmental and T3-dependent regulation of genes that code for 
enzymes that catalyze active DNA demethylation in the tadpole brain (Chapter 3). Using real-
time RT-qPCR I found that mRNAs for the tet2, tet3, apobec2, gadd45β, gadd45γ and tdg genes 
increased during metamorphosis. Of these six genes, tet3, gadd45γ and tdg mRNAs also showed 
T3-dependent increases in premetamorphic tadpole brain, suggesting that these three enzymes 
may be responsible for T3-dependent DNA demethylation of neural cells during metamorphosis 
(discussed below).  
It is still not well understood what roles TET3, GADD45γ and TDG proteins play in 
postembryonic neurological development, but studies in embryos suggest their roles for neural 
cell differentiation. The ten-eleven translocation dioxygenase 3 (tet3) catalyze the conversion of 
5-mC to 5-hydroxymethylcytosine (5-hmC) in vertebrate genomes to initiate active DNA 
demethylation (15). In situ hybridization analysis of embryonic mouse brain shows that Tet3 
mRNA increases between embryonic days 13.5 and 15.5 at the cortical plate where neuronal 
cells undergo differentiation, which correlated with increase in the abundance of 5-hmC (16). In 
the Xenopus genome two homologous Tet genes (tet2 and tet3) have been identified. A previous 
study showed that TET3 plays a role in neural cell (eye) development during embryogenesis by 
controlling expression of genes that are involved in neurogenesis (17). The growth arrest and 
DNA damage 45 gamma (GADD45γ) is a scaffold protein that interacts with various types of 
enzymes that are involved in nucleotide excision repair (NER) and base-excision repair (BER) 
pathways (reviewed in Shafer, 2013 (18)). Histochemical analyses showed that gadd45γ mRNA 
is expressed in cells undergoing differentiation, such as primary neuron precursors in Xenopus 
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neurula (19) and in the developing central nervous system of mouse embryos (20). Thymine 
DNA glycosylase (TDG) recognizes T:G mismatch in the genome and activates the BER 
pathway to correct the mismatch (reviewed in Kohli and Zhang, 2013 (21)). In addition to this 
known role, recent studies showed that TDG catalyzes the removal of 5-formylcytosine (5-fC) 
and 5-carboxycytosine (5-caC) (22), modified cytosines generated by TET-mediated oxidation of 
5-hmC (23,24). Nothing is known about expression pattern of the TDG gene in the developing 
nervous system.  
Conducting histochemical analysis using in situ hybridization or immunohistochemistry 
for tet3, gadd45γ and tdg genes will be informative for developing more specific hypotheses 
about their potential roles in the developing brain. Whole body deletion of either Tet3 or Tdg 
gene is embryonic lethal in mouse (25,26), while deletion of the Gadd45γ gene does not interfere 
with normal mouse development (27). Generating mice carrying neural cell-specific deletion of 
Tet3 and/or Tdg genes will also be useful for studying their roles in postnatal neurological 
development. Future studies should also investigate roles for TET3, GADD45γ and TDG 
proteins in mediating T3 actions on DNA demethylation. One approach is to knock down 
expression of these genes, for example, in tadpole brain by delivering morpholino antisense 
oligonucleotides using electroporation-mediated gene transfer (28), and then to analyze the effect 
of such manipulation on T3-dependent DNA demethylation at specific loci such as T3REs for klf9 
and dnmt3a genes (Chapter 3; discussed below). If tet3, gadd45γ and/or tdg mediate T3-
dependent DNA demethylation, I predict that the knock down will impair T3-dependent changes 
in DNA methylation, such that the locus will remain methylated in response to T3. 
 
Developmental and T3-dependent modulation of the neural cell methylome  
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I found that the genome of tadpole neural cells became demethylated during 
metamorphosis using ELISA, LUMA, cytosine extension assays (Chapter 3) and MethylCap-seq 
(Chapter 4). As discussed before, the degree of changes in DNA methylation detected by these 
independent assays varied. While 5-mC ELISA detected roughly 50% reduction in methylated 
cytosines between the onset of metamorphosis and metamorphic climax (NF stages 50 and 62), 
the other three assays detected reduction ranging between 0.6 and 2%. This discrepancy is likely 
due to differences in the sensitivity of these assays; ELISA can detectmethylated cytosines in any 
sequence context, while other assays detect methylated cytosines mainly in CpG context. This 
discrepancy, however, may also suggest that non-CpG (CpH) methylation may undergo more 
dynamic changes in tadpole brain during metamorphosis. A recent genome-wide analysis of 5-
mC in the developing mouse and human brains showed that CpH methylation exhibited more 
dynamic changes than CpG methylation did (5). Future studies should investigate whether 
changes in CpH methylation account for a larger decline of 5-mC detected by ELISA in the 
tadpole brain. As a preliminary approach, it will be informative to conduct sequence motif 
analysis of MethylCap-seq data to investigate if CpH sequence is enriched in captured DNA.  
Cell proliferation in tadpole brain exhibits a robust increase around mid-
prometamorphosis (NF stage 56) (9) (Fig. 5.1). Therefore, while activation of tet3, gadd45γ and 
tdg genes suggests active DNA demethylation of tadpole neural cells during metamorphosis, 
passive DNA demethylation through cell divisions may also contribute to the overall decline of 
5-mC, which plays a prominent role during mammalian embryogenesis (reviewed in Hackett and 
Surani, 2013 (29)). More research is required to support that the active mechanism is responsible 
for DNA demethylation that occurred during metamorphosis in the tadpole brain. The TET 
enzymes catalyze the conversion of 5-mC to 5-hmC to initiate active DNA demethylation (15). 
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Therefore, if the active mechanism is involved, I predict that there is a corresponding increase in 
the abundance of 5-hmC in tadpole brain during metamorphosis. This can be measured at the 
whole genome level using ELISA or in a locus-specific manner using a targeted approach, such 
as 5-hmC DNA immunoprecipitation. Another approach is to measure the enzymatic activity of 
DNA demethylases in tadpole brain, which can be assayed by mixing cell extract isolated from 
the brain with DNA fragments of known methylation status (e.g. in vitro methylated plasmids). 
If active DNA demethylation is supported, I predict that brain cell extract from later stage of 
metamorphosis exhibits a higher DNA demethylase activity than th cell extract isolated from an 
earlier stage tadpole.  
More research is required to determine the extent to which T3 accounts for developmental 
changes in DNA methylation. While I found a few examples of T3-dependent locus-specific 
DNA demethylation, I did not find evidence to support T3-dependent DNA demethylation at a 
global scale (Chapter 3). There are several possibilities to explain the lack of such evidence. First, 
the duration of T3 treatment may be too short to recapitulate developmental changes in DNA 
methylation. While four-day treatment of premetamorphic tadpoles with exogenous T3 was 
enough to induce locus-specific DNA demethylation, during spontaneous metamorphosis 
Xenopus tadpoles are exposed to endogenous T3 for a much longer period of time, as it takes 
roughly 40 days to complete tadpole metamorphosis (2). Second, as I discovered that T3 activates 
both groups of genes that are involved in DNA methylation (dnmt3a) and DNA demethylation 
(tet3, gadd45γ and tdg) in tapole brain (Chapter 2 and 3), it is likely that T3 treatment of 
premetamorphic tadpoles causes simultaneous, opposing changes in DNA methylation, and 
hence, T3-dependent changes in DNA methylation may not be detectable by approaches to 
measure the bulk level of 5-mC such as ELISA and LUMA. A better approach to investigate T3-
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dependent change in DNA methylation is to conduct analysis that allows us to detect locus-
specific changes, and therefore, conducting MethylCap-seq analysis on DNA isolated from 
premetamorphic tadpoles treated with T3 will be informative to determine the extent to which T3 
is responsible for developmental changes in DNA methylation.   
 
Role of thyroid hormone receptors in modulation of the local DNA methylome 
I discovered that genomic regions that contain T3REs for known T3-response genes 
(krüpple-like factor 9 - klf9 and dnmt3a) became demethylated during metamorphosis in tadpole 
brain; treatment of premetamorphic tadpoles with exogenous T3 also induced DNA 
demethylation around these loci. Although klf9 and dnmt3a T3REs themselves do not contain 
CpG sequences, in vitro methylating DNA sequences that encompass these T3REs (where 
flanking regions contain CpG dinucleotides) strongly inhibited T3-dependent transactivity. 
These findings together suggest two things. First, DNA demethylation of T3REs may be 
important for activation of T3-regulated genes in tadpole brain during metamorphosis. Future 
study should extend this finding by conducting TR ChIP-seq analysis in tadpole brain to 
determine the extent of overlap between TR binding sites and regions that become demethylated 
during metamorphosis. Second, the findings suggest that liganded TRs may play a role in 
recruitment of enzymes that catalyze DNA demethylation to modulate the local methylation state 
of their binding sites, and future studies should investigate the mechanisms by which klf9 and 
dnmt3a T3REs become demethylated. This may occur through several non-mutually exclusive 
mechanisms. First, through their ability to recruit histone-modifying enzymes, liganded TRs may 
modulate chromatin architecture to expose binding sites in the genome for enzymes that 
demethylate DNA, such as for the TET enzymes with the CXXC DNA-binding motif (30). 
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Second, liganded TRs may recruit enzymes that demethylate DNA through direct protein-protein 
interaction, as previous study has shown that the TDG protein interacts in vitro with nuclear 
hormone receptors including TRα and RXRα (31). Future studies should address these 
possibilities by investigating: whether T3-dependent DNA demethylation requires recruitment of 
histone-modifying enzymes at TR binding sites; whether DNA demethylases are recruited to TR 
binding sites upon hormone binding; and whether liganded TRs can directly interact with 
enzymes that catalyze DNA demethylation, such as TDG.  
Published studies generally support the correlation between changes in gene expression 
and DNA methylation changes that occur within regulatory loci such as promoters and enhancers 
(5,32,33). In Chapter 4, I also found a weak, but statistically significant correlation between 
DNA demethylation and activation of genes that are found within 50 kb vicinity of differentially 
methylated regions. However, more research is required to establish a clear functional 
connection between these correlated changes. It is still unclear whether changes in DNA 
methylation lead to gene expression changes (cause), or whether gene expression changes 
precede changes in DNA methylation at regulatory loci (consequence). My findings of DNA 
demethylation at T3REs may provide a useful model to investigate the functional linkage 
between changes in DNA methylation and changes in gene expression, as a regulatory role of 
T3RE is clearly established for some of T3-regulated genes, such as klf9 (34). Future study should 
investigate the effect of modulating the methylation state at T3REs on expression of the regulated 
genes using TALEN- or CRISPR/Cas9-mediated targeting of the TET1 catalytic domain (35). 
Since DNA demethylation at T3REs correlated with activation of T3-regulated genes in tadpole 
brain during metamorphosis (Chapter 3), I predict that TET1-mediated DNA demethylation at 
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T3REs either causes precocious activation of the regulated genes, or causes those genes to be 
more responsive to T3 by potentially lowering the dose of T3 that requires for activation. 
 
Concluding remarks 
 Thyroid hormone and DNA methylation both play crucial roles in postembryonic brain 
development; however, roles for T3 in modulating DNA methylation have not been investigated 
prior to my dissertation research. My discoveries support the hypothesis that T3 modulates DNA 
methylation through activation of genes involved in DNA methylation and active DNA 
demethylation. Although more work is required to identify gene expression programs that are 
commonly regulated by T3 signaling and DNA methylation, my thesis work laid an important 
groundwork to establish the linkage between T3 signaling and DNA methylation, and broadened 
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Fig. 5.1. Summary of changes in Xenopus tadpole brain during metamorphosis. Top: 5-
methylcytosine (analyzed by ELISA; Fig 3.1A) and expression of genes that are involved in 
DNA methylation (dnmt3a; Fig. 2.1D) and active DNA demethylation (tet3 only; gadd45γ and 
tdg showed similar profiles; Fig 3.1B). Middle: Plasma thyroid hormone concentration (T3 and 
T4; Fig 1.1). Bottom: Cell proliferation as quantified by BrdU immunohistochmistry. The middle 
and bottom figures were adapted and modified with permission (Middle – Shi (2000); Bottom - 
Denver et al. (2009)) 
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